Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 09/26/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Sept. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
- 09/25/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/23/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/21/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/19/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Sept. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
- 09/17/2024
|
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 09/16/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 15, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/15/2024
|
Cardlytics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Cardlytics (CDLX)
- NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/13/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/13/2024
|
Cardlytics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - CDLX
- NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/12/2024
|
Cardlytics Inc May Have Defrauded Investors And Impacted Individuals Can Join The Schall Law Firm's Inquiry
- LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/12/2024
|
CDLX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Cardlytics, Inc. investment
- NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/11/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/11/2024
|
Shareholders that Lost Money on Cardlytics, Inc.(CDLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/11/2024
|
The Schall Law Firm Is Looking Into Whether Cardlytics, Inc. Violated Securities Regulations And Shareholders Are Urged To Reach Out
- LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/11/2024
|
Shareholders that Lost Money on Cardlytics, Inc. (CDLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/10/2024
|
Cardlytics Inc May Have Defrauded Investors And Those With Losses Should Join The Schall Law Firm's Inquiry
- LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/10/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Sept. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
- 09/09/2024
|
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses.
- NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/09/2024
|
The Schall Law Firm Is Looking Into Whether Cardlytics, Inc. Committed Securities Law Violations And Stockholders Are Invited To Take Part
- LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/09/2024
|
Levi & Korsinsky Reminds Shareholders of an Investigation into Cardlytics, Inc. (CDLX) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/09/2024
|
Levi & Korsinsky Reminds Cardlytics Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CDLX
- NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/07/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/07/2024
|
Cardlytics Inc May Have Defrauded Investors And Those With Losses Should Contact The Schall Law Firm About An Investigation
- LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/07/2024
|
ATTENTION CDLX SHAREHOLDERS: Investors Who Lost Money on Cardlytics, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
- NEW YORK, NY / ACCESSWIRE / September 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/06/2024
|
Investors With Losses In Cardlytics Inc Are Encouraged To Contact The Schall Law Firm About An Investigation Into Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/06/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/05/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 09/05/2024
|
Levi & Korsinsky Reminds Shareholders of an Investigation into Cardlytics, Inc. (CDLX) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/05/2024
|
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now . The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 09/05/2024
|
Cardlytics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- CDLX
- NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/05/2024
|
The Schall Law Firm Seeks The Public's Participation In A Securities Fraud Inquiry Into Cardlytics Inc.
- LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/05/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CDLX
- NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 09/04/2024
|
Cardlytics Inc Is Being Looked Into For Violating Securities Regulations And Stakeholders Are Urged To Spearhead The Investigation
- LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/04/2024
|
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
- LOS ANGELES , Sept. 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of the securities laws.
- 09/04/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX).
- 09/03/2024
|
The Schall Law Firm Wants Cardlytics Inc. Shareholders To Join An Inquiry Into Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/03/2024
|
Cardlytics Inc May Have Committed Infractions Of Securities Regulations And Impacted Investors Are Encouraged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/02/2024
|
The Schall Law Firm Invites Individuals With Losses In Cardlytics Inc. To Help The Firm Investigate Securities Law Violations
- LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 09/01/2024
|
Shareholders Can Join An Inquiry With The Schall Law Firm Into Cardlytics Inc's Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/31/2024
|
Cardlytics Inc. May Have Violated Securities Regulations And Individuals Are Urged To Assist The Schall Law Firm In An Investigation
- LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/30/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
- NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/29/2024
|
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 08/29/2024
|
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses
- NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/29/2024
|
Cardlytics Inc. Is Being Looked At For Potential Securities Law Violations And Investors Are Encouraged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/29/2024
|
Levi & Korsinsky Reminds Cardlytics Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CDLX
- NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/29/2024
|
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Clients to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/29/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") CDLX. newaction@pomlaw.com The investigation concerns whether Cardlytics and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- 08/28/2024
|
Cardlytics, Inc. (CDLX) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/28/2024
|
The Schall Law Firm Is Seeking Shareholders In Cardlytics Inc To Join An Inquiry Into Possible Securities Fraud
- LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/28/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/28/2024
|
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Shareholders to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/28/2024
|
ATTENTION Cardlytics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/27/2024
|
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/27/2024
|
Cardlytics Inc May Have Engaged In Illegal Practices And The Schall Law Firm Wants Investors To Help The Investigation
- LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/27/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Cardlytics, Inc. (CDLX)
- NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/27/2024
|
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Shareholders to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/27/2024
|
CDLX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cardlytics, Inc. Shareholders Who Lost Money
- NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/26/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/26/2024
|
Investors Who Lost Money on Cardlytics, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/26/2024
|
Shareholders Are Invited To Join The Schall Law Firm In A Securities Fraud Inquiry Into Cardlytics Inc
- LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/26/2024
|
Cardlytics, Inc. (CDLX) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/26/2024
|
CDLX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/26/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Cardlytics, Inc. (CDLX) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/25/2024
|
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK , Aug. 25, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/25/2024
|
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses.
- NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/25/2024
|
Cardlytics Inc Is Being Investigated By The Schall Law Firm For Possible Securities Law Infractions And Investors Can Participate
- LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/25/2024
|
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 25, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/25/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cardlytics, Inc. (CDLX) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/24/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/24/2024
|
The Schall Law Firm Has Opened An Inquiry Into Cardlytics Inc. For Securities Fraud And Stakeholders Are Urged To Join
- LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/24/2024
|
Cardlytics, Inc. (CDLX) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/23/2024
|
Cardlytics Inc. Is Being Investigated By The Schall Law Firm For Securities Law Violations And Impacted Investors Are Invited To Be A Part
- LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/23/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Cardlytics, Inc. (CDLX)
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/23/2024
|
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm Today!
- NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/23/2024
|
An Investigation Has Commenced on Behalf of Cardlytics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CDLX Losses.
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/22/2024
|
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
- LOS ANGELES , Aug. 22, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/22/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/22/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/22/2024
|
The Schall Law Firm Urges Cardlytics Inc. Investors To Join A Securities Fraud Investigation
- LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/22/2024
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Cardlytics, Inc. (CDLX)
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/22/2024
|
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Stockholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/22/2024
|
Cardlytics, Inc. (CDLX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/21/2024
|
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/21/2024
|
Did Cardlytics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - CDLX
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/21/2024
|
Shareholders With Losses In Cardlytics Inc. Are Encouraged To Participate In Securities Fraud Case With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/21/2024
|
CDLX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cardlytics, Inc. Shareholders Who Lost Money
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/21/2024
|
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Stockholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/21/2024
|
Investors who lost money on Cardlytics, Inc. should contact Levi & Korsinsky about an ongoing investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/20/2024
|
Investors With Losses In Cardlytics Inc. Invited To Join The Schall Law Firm In Securities Fraud Case
- LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/20/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CDLX
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/20/2024
|
CDLX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Shareholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/20/2024
|
Cardlytics, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CDLX
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/19/2024
|
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 08/19/2024
|
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- ATLANTA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that, on August 19, 2024, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 49,900 restricted stock units of Cardlytics to seven newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).
- 08/19/2024
|
Cardlytics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CDLX
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/19/2024
|
Shareholders With Losses In Cardlytics Inc. Encouraged To Participate In Securities Fraud Case With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/19/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/19/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Cardlytics, Inc. (CDLX) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/19/2024
|
CDLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Shareholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/19/2024
|
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK--(BUSINESS WIRE)---- $CDLX #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX. Investigation Details Cardlytics claimed to the market that its technology initiatives were “really paying off.” How.
- 08/18/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
- NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/18/2024
|
Cardlytics Inc. Investors Can Participate In Securities Fraud Case With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/18/2024
|
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Shareholders to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/18/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Aug. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/17/2024
|
Levi & Korsinsky Announces an Investigation on Behalf of Cardlytics, Inc. (CDLX) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/17/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CDLX
- NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/17/2024
|
Cardlytics Inc. Shareholders Invited To Join Securities Fraud Case With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/17/2024
|
Investors who lost money on Cardlytics, Inc. should contact Levi & Korsinsky about an ongoing investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/16/2024
|
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK , Aug. 16, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/16/2024
|
CDLX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Cardlytics, Inc.
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/16/2024
|
CDLX Investors Encouraged To Join Cardlytics, Inc. Fraud Case With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/16/2024
|
Shareholders That Lost Money on Cardlytics, Inc. (CDLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/16/2024
|
CDLX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/16/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cardlytics, Inc. (CDLX) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/15/2024
|
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
- NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/15/2024
|
Cardlytics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CDLX
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/15/2024
|
Shareholders That Lost Money on Cardlytics, Inc. (CDLX) Should Contact Levi & Korsinsky About Securities Fraud Investigation - CDLX
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/15/2024
|
CDLX Investors Have Capability To Join Cardlytics, Inc. Securities Fraud Investigation With The Schall Law Firm
- LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/15/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cardlytics, Inc. (CDLX) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/15/2024
|
CDLX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cardlytics, Inc. Shareholders Who Lost Money
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/14/2024
|
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, CA / ACCESSWIRE / August 14, 2024 / Hagens Berman urges Cardlytics, Inc. (NASDAQ:CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 08/14/2024
|
CDLX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Cardlytics, Inc.
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/14/2024
|
CDLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Cardlytics, Inc. and Encourages Investors to Contact the Firm!
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX). Investors who purchased Cardlytics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CDLX.
- 08/14/2024
|
Levi & Korsinsky Reminds Cardlytics Investors of the Ongoing Investigation into Potential Violations of Securities Laws - CDLX
- NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/14/2024
|
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
- LOS ANGELES , Aug. 14, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ: CDLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 08/14/2024
|
CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)--CDLX Investors Have Opportunity to Join Cardlytics, Inc. Securities Fraud Investigation with the Schall Law Firm.
- 08/13/2024
|
CDLX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Cardlytics, Inc. investment
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/13/2024
|
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
- SAN FRANCISCO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Cardlytics, Inc. (NASDAQ: CDLX) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
- 08/13/2024
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Cardlytics, Inc. (CDLX) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/13/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/13/2024
|
Cardlytics Being Investigated on Behalf of Cardlytics, Inc. Investors. Contact Levi & Korsinsky For Details
- NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/12/2024
|
SHAREHOLDER ALERT: Investigation Into Cardlytics, Inc. (CDLX) Announced byHolzer & Holzer, LLC
- ATLANTA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) complied with federal securities laws. On August 7, 2024, Cardlytics reported financial results for its second quarter ended June 30, 2024, including a decrease of 9% year-over-year in revenue, stating “our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives.” Following this news, the price of the Company's stock dropped.
- 08/12/2024
|
Cardlytics, Inc. (CDLX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/11/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/11/2024
|
CDLX ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cardlytics, Inc. Shareholders Who Lost Money
- NEW YORK, NY / ACCESSWIRE / August 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/10/2024
|
CARDLYTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cardlytics, Inc. on Behalf of Cardlytics Stockholders and Encourages Investors to Contact the Firm
- NEW YORK, Aug. 10, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ:CDLX) on behalf of Cardlytics stockholders. Our investigation concerns whether Cardlytics has violated the federal securities laws and/or engaged in other unlawful business practices.
- 08/10/2024
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company's possible violations of federal securities laws. On August 7, 2024, Cardlytics released its second quarter 2024 financial results, missing consensus estimates due to “slower-than-anticipated billings growth coupled with higher consumer incentives.” Specifically, the Company stated that it had enco.
- 08/10/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ: CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/09/2024
|
Cardlytics, Inc. (CDLX) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/08/2024
|
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc. - CDLX
- NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or the "Company") (NASDAQ:CDLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 08/08/2024
|
Cardlytics, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CDLX
- NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cardlytics, Inc. ("Cardlytics") (NASDAQ:CDLX) concerning possible violations of federal securities laws. Cardlytics announced its second quarter 2024 financial results on August 7, 2024, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution to $36.4 million; the Company also disclosed that Karim Temsamani stepped down as Chief Executive Officer and from the Board of Directors.
- 08/08/2024
|
Johnson Fistel Begins Investigation into Cardlytics Following a Significant Drop in the Company's Stock
- SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Cardlytics, Inc. (NASDAQ: CDLX) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.
- 08/08/2024
|
Why Is Cardlytics (CDLX) Stock Down 57% Today?
- Cardlytics (NASDAQ: CDLX ) stock is falling hard on Thursday after the advertising platform operator released its latest earnings and announced a leadership change. The bad news in the earnings report starts with its revenue of $69.64 million.
- 08/08/2024
|
Cardlytics Announces Second Quarter 2024 Financial Results
- ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2024.
- 08/07/2024
|
Cardlytics Appoints Amit Gupta as CEO
- ATLANTA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced that the Board of Directors has appointed Amit Gupta, Chief Operating Officer and General Manager of Bridg, as its next Chief Executive Officer of Cardlytics, effective August 16, 2024. He will also join the Cardlytics Board of Directors on that date. Mr. Gupta will succeed Karim Temsamani, who is stepping down as Chief Executive Officer and from the Board of Directors to pursue another professional opportunity.
- 08/07/2024
|
Cardlytics Announces Timing of Its Second Quarter 2024 Earnings Release
- ATLANTA, July 24, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its second quarter ended June 30, 2024 financial results will be released on August 7, 2024, after market close. The results will be discussed via conference call at 5:00 PM (ET) / 2:00 PM (PT).
- 07/24/2024
|
Why Cardlytics Stock Collapsed on Thursday
- Cardlytics beat on earnings but missed on sales last night. Investors appear to be overreacting -- but actually, they're justified considering the size of Cardlytics' Q1 loss.
- 05/09/2024
|
Why Is Cardlytics (CDLX) Stock Down 29% Today?
- Cardlytics (NASDAQ: CDLX ) stock is falling on Thursday after the advertising platform operator released its earnings report for the first quarter of 2024. That earnings report starts with revenue of $67.61 million for the quarter.
- 05/09/2024
|
Cardlytics, Inc. (CDLX) Q1 2024 Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Nick Lynton - Chief, Legal and Privacy Officer Karim Temsamani - CEO Alexis DeSieno - CFO Conference Call Participants Kyle Peterson - Needham Jason Kreyer - Craig Hallum Jacob Stephan - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the Cardlytics Earnings Conference Call.
- 05/08/2024
|
Cardlytics Announces First Quarter 2024 Financial Results
- ATLANTA, May 08, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended March 31, 2024.
- 05/08/2024
|
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that, on May 1, 2024, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 38,500 restricted stock units of Cardlytics to five newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).
- 05/02/2024
|
Liane Hornsey Appointed to Cardlytics Board of Directors
- ATLANTA, April 09, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, is excited to announce the appointment of Liane Hornsey to its Board of Directors. In connection with her appointment to the Board of Directors, Hornsey was also appointed to the Board's Compensation Committee, and she will assume the role of Compensation Committee Chairperson upon Cardlytics' upcoming Annual Meeting of Stockholders in May 2024.
- 04/09/2024
|
Why Cardlytics Stock Skyrocketed 75% Last Month
- Cardlytics stock skyrocketed because its business showed improved trends. The company then refinanced some of its debt at a higher rate, which troubled investors.
- 04/02/2024
|
Cardlytics Prices $150.0 Million Convertible Senior Notes Offering
- ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks' digital channels, today announced the pricing of its offering of $150.0 million aggregate principal amount of 4.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on April 1, 2024, subject to customary closing conditions. Cardlytics also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $22.5 million aggregate principal amount of notes.
- 03/26/2024
|
Why Cardlytics Stock Tanked by 33% Today
- The digital advertising specialist is issuing at least $150 million worth of senior convertible notes. These securities can be converted into equity under certain conditions.
- 03/26/2024
|
Cardlytics Announces Proposed Convertible Senior Notes Offering
- ATLANTA, March 26, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX) (“Cardlytics”), an advertising platform in banks' digital channels, today announced its intention to offer, subject to market and other conditions, $150.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cardlytics also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $22.5 million aggregate principal amount of notes.
- 03/26/2024
|
Stellantis, Other Beneficial Owners Love These 7 Stocks
- Beneficial owners, including giant automaker Stellantis, portfolio managers, and an activist investor, have bolstered their stakes with huge insider purchases reported in the past week.
- 03/24/2024
|
Here's Why Cardlytics Stock Absolutely Skyrocketed Today
- Cardlytics finished 2023 with record revenue and returned to positive adjusted earnings, much to the surprise of the market. The company expects ongoing growth in the coming quarter.
- 03/15/2024
|
The end of the bear reign? Navigating Cardlytics' potential reversal
- Leading digital advertising and financial technology company, Cardlytics (NASDAQ:CDLX), reported its fourth-quarter results after market closing yesterday. Although the company missed analysts' EPS and revenue expectations by $0.03 and $0.35 million, respectively, its stock jumped over 37% post-market buoyed by optimistic guidance for Q1 2024.
- 03/15/2024
|
Cardlytics, Inc. (CDLX) Q4 2023 Earnings Call Transcript
- Cardlytics, Inc. (CDLX) Q4 2023 Earnings Call Transcript
- 03/14/2024
|
Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
- ATLANTA, March 14, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the fourth quarter and full year ended December 31, 2023. Supplemental information is available on the Investor Relations section of the Cardlytics website at http://ir.cardlytics.com/.
- 03/14/2024
|
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- ATLANTA, March 08, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that, on March 6, 2024, the Compensation Committee of Cardlytics's Board of Directors granted an aggregate of 198,183 restricted stock units of Cardlytics to 8 newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).
- 03/08/2024
|
Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
- ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its fourth quarter ended December 31, 2023 financial results will be released on March 14, 2024, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 02/29/2024
|
Why Cardlytics Stock Skyrocketed Today
- Cardlytics reached a settlement in a lawsuit regarding an acquisition. The acquisition was intended to better position its business for a changing advertising landscape.
- 01/29/2024
|
Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
- Expects Preliminary Results to Allow Extension of Credit Facility Maturity Date to April 2025 Expects Preliminary Results to Allow Extension of Credit Facility Maturity Date to April 2025
- 01/29/2024
|
Cardlytics Appoints Two New Members to its Board of Directors
- ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, is excited to announce the appointment of Andre Fernandez and Jon Francis to its Board of Directors. Additionally, John Balen and David Adams have retired from the Board effective as of January 1, 2024. In connection with these Board changes, Jack Klinck has assumed the role of Chairperson of the Board.
- 01/02/2024
|
Cardlytics, Inc. (CDLX) Q3 2023 Earnings Call Transcript
- Cardlytics, Inc. (CDLX) Q3 2023 Earnings Call Transcript
- 11/08/2023
|
Cardlytics Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast
- ATLANTA, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its third quarter ended September 30, 2023 financial results will be released on November 8, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 10/26/2023
|
Checking Back In On Cardlytics
- Today, we revisit small cap concern Cardlytics, Inc. for the first time since September of last year. The company is making solid headway in reducing costs under new leadership and the stock took off temporarily after second quarter results were posted in August.
- 10/19/2023
|
Cardlytics, Inc. (CDLX) Q2 2023 Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Nick Lynton - Chief, Legal and Privacy Officer Robert Robinson - Director of Corporate Development and Investor Relations Karim Temsamani - Chief Executive Officer Conference Call Participants Jason Kreyer - Craig-Hallum Operator Good day and thank you for standing by. Welcome to the Q2 2023 Cardlytics, Inc. Earnings Conference Call.
- 08/01/2023
|
Cardlytics (CDLX) Reports Q2 Loss, Tops Revenue Estimates
- Cardlytics (CDLX) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.65 per share a year ago.
- 08/01/2023
|
Cardlytics (CDLX) Surges 13.2%: Is This an Indication of Further Gains?
- Cardlytics (CDLX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 07/14/2023
|
CDLX stock in focus as Cardlytics' revenue share to JPMorgan decreases
- In 2018, Cardlytics (NASDAQ: CDLX), a tech company that operates as an advertising platform in banks' digital channels, and JPMorgan Chase Bank (NYSE: JPM) struck a PayTech deal.
- 07/07/2023
|
Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year?
- Here is how Cardlytics (CDLX) and Trane Technologies (TT) have performed compared to their sector so far this year.
- 06/19/2023
|
Does Cardlytics (CDLX) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?
- The consensus price target hints at a 49.3% upside potential for Cardlytics (CDLX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 05/08/2023
|
Cardlytics, Inc. (CDLX) Q1 2023 Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Nick Lynton – Chief Legal and Privacy Officer Karim Temsamani – Chief Executive Officer Andy Christiansen – Chief Financial Officer Conference Call Participants Kyle Peterson – Needham Operator Good day and thank you for standing by. Welcome to the Q1 2023 Cardlytics, Inc. Earnings Conference Call.
- 05/06/2023
|
Cardlytics Announces Timing of Its First Quarter 2023 Financial Results Conference Call and Webcast
- ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its first quarter ended March 31, 2023 financial results will be released on Thursday, May 4, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 04/24/2023
|
Cardlytics (CDLX) Soars 80.9%: Is Further Upside Left in the Stock?
- Cardlytics (CDLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 04/05/2023
|
Why Is Cardlytics (CDLX) Stock Up 70% Today?
- One of today's biggest gainers in an otherwise down market is Cardlytics (NASDAQ: CDLX ). At the time of this writing, CDLX stock is surging around 70% higher on extreme momentum and high volume.
- 04/04/2023
|
Stock to watch: Cardlytics (CDLX) raises Q1 revenue guidance as buying pressure mounts
- The stock of finance-focused digital advertising platform Cardlytics (NASDAQ: CDLX), which had been on the downside for most of the past month, has suddenly experienced a significant uptick upon the company announcing its updated guidance for the first quarter of 2023.
- 04/04/2023
|
Cardlytics stock soars more than 30% after company boosts forecast
- Cardlytics Inc. shares CDLX, +32.74% were shooting more than 30% higher early in Tuesday's session after the digital-advertising company boosted its quarterly forecast. Cardlytics now expects $63.5 million to $66.5 million in revenue for the first quarter, whereas its prior outlook was for $54.0 million to $63.0 million.
- 04/04/2023
|
Cardlytics seeks new CFO after current one announces resignation
- Cardlytics Inc. CDLX, -15.19% said late Wednesday that its chief financial officer is resigning over the summer. Andy Christiansen told the company on Friday that his last day is July 21, but will remain for a transition period, the company said.
- 03/22/2023
|
Cardlytics Is Moving Towards Positive Free Cash Flow
- CDLX's Q4 numbers are bad, but it was expected. The newly appointed CEO is implementing significant modifications to the company's operations in order to increase efficiency.
- 03/05/2023
|
Cardlytics, Inc. (CDLX) Q4 2022 Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q4 2022 Earnings Conference Call March 1, 2023 5:00 PM ET Company Representatives Karim Temsamani - Chief Executive Officer Andy Christiansen - Chief Financial Officer Nick Lynton - Chief Legal and Privacy Officer Conference Call Participants Kyle Peterson - Needham & Company Douglas Anmuth - JPMorgan Jason Kreyer - Craig-Hallum Operator Hello! And thank you for standing by.
- 03/01/2023
|
Cardlytics (CDLX) Reports Q4 Loss, Misses Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of 45.28% and 2.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 03/01/2023
|
Strength Seen in Cardlytics (CDLX): Can Its 12.1% Jump Turn into More Strength?
- Cardlytics (CDLX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 01/30/2023
|
Cardlytics to Present at the 2022 Raymond James Technology Investors Conference
- ATLANTA, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced it will present at the 2022 Raymond James Technology Investors Conference.
- 12/01/2022
|
After Plunging 52% in 4 Weeks, Here's Why the Trend Might Reverse for Cardlytics (CDLX)
- Cardlytics (CDLX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 11/08/2022
|
Cardlytics stock cut in half amid 'continued uncertainty' from advertisers
- Cardlytics Inc. shares CDLX, -53.41% ended Wednesday's session down 53% after the company, which provides marketing solutions, delivered a forecast that fell well short of what analysts had been expecting. JPMorgan analyst Doug Anmuth wrote following the Tuesday afternoon report that Cardlytics guided for a roughly 6% year-over-year decline in fourth-quarter revenue at the midpoint, while the consensus view had been for growth of approximately 11%.
- 11/02/2022
|
Here's Why Cardlytics Stock Sank to an All-Time Low on Wednesday
- The business trends are worse than management expected.
- 11/02/2022
|
Cardlytics, Inc. (CDLX) Q3 2022 Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q3 2022 Earnings Conference Call November 1, 2022 5:00 PM ET Company Representatives Nick Lynton - Chief Legal Officer Karim Temsamani - Chief Executive Officer Andy Christiansen - Chief Financial Officer Conference Call Participants Kyle Peterson - Needham Wesley Sanford - JPMorgan Aaron Kessler - Raymond James Operator Thank you for standing by, and welcome to the Third Quarter 2022 Cardlytics, Inc., Earnings Conference Call. I will now hand the conference over to Nick Lynton.
- 11/01/2022
|
Cardlytics (CDLX) Reports Q3 Loss, Misses Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of 7.41% and 2.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/01/2022
|
Cardlytics Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast
- ATLANTA, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its third quarter ended September 30, 2022 financial results will be released on Tuesday, November 1, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 10/19/2022
|
These Are The Ten Best And Worst Performing Small-Cap Stocks In July 2022
- The small-cap Russell 2000 gained over 10% in July, compared to a jump of 9.1% for the S&P 500.
- 08/22/2022
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q2 2022 Results - Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET Company Representatives Lynne Laube - Chief Executive Officer Andy Christiansen - Chief Financial Officer Nick Lynton - Chief Legal Officer Conference Call Participants Kyle Peterson - Needham Doug Anmuth - JPMorgan Jason Kreyer - Craig-Hallum Operator Hello! Thank you for standing by, and welcome to the Second Quarter 2022 Cardlytics, Inc., Earnings Conference Call.
- 08/02/2022
|
Cardlytics (CDLX) Reports Q2 Loss, Lags Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of -20.37% and 1.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/02/2022
|
Needham sets a ‘Buy' rating for Cardlytics as JPM acquires Figg; What's next for CDLX?
- Independent investment bank and asset management firm Needham & Company, which specializes in financings for growth companies, has set a.
- 07/20/2022
|
Cardlytics Announces Timing of Its Second Quarter 2022 Financial Results Conference Call and Webcast
- ATLANTA, July 19, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its second quarter ended June 30, 2022 financial results will be released on Tuesday, August 2, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 07/19/2022
|
Cardlytics: Key Challenges To Look At Before It Takes Off
- Cardlytics has issues conducting multi-touch attribution models, which might hinder some advertisers from adopting the platform. The capabilities to quickly scale and conduct offer campaigns are limited because of the lack of automation.
- 07/14/2022
|
Cardlytics Has A Lot To Offer As A Large Advertising Platform
- By partnering with banks, Cardlytics has 178M monthly active users (MAU) and access to data of 1 in 2 US purchase transactions. This is very unique. CDLX is building a true ecosystem for advertising and consumer research. It benefits every participant on the platform!
- 06/23/2022
|
Cardlytics to Present at the Bank of America 2022 Global Technology Conference
- ATLANTA, May 31, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced it will present at the Bank of America 2022 Global Technology Conference.
- 05/31/2022
|
Cardlytics rallies after earnings growth but volatility and risk remain
- Cardlytics (NASDAQ: CDLX) was up 6% in premarket trading on Tuesday, May 3 after the company reported an estimate beat.
- 05/04/2022
|
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of 44.93% and 3.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/02/2022
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q1 2022 Results - Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2022 Earnings Conference Call May 2, 2022 5:00 PM ET Company Participants Kirk Somers - Chief Legal & Privacy Officer Lynne Laube - Chief Executive Officer & Co-Founder Andy Christiansen - Chief Financial Officer Conference Call Participants Aaron Kessler - Raymond James Kyle Peterson - Needham Jason Kreyer - Craig-Hallum Jeff Cantwell - Wells Fargo Nat Schindler - Bank of America Operator Thank you for standing by, and welcome to the First Quarter 2022 Cardlytics, Inc. Earnings Conference Call. At this time, all participants are in listen-only mode.
- 05/02/2022
|
Cardlytics Announces Timing of Its First Quarter 2022 Financial Results Conference Call and Webcast
- ATLANTA, April 19, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its first quarter ended March 31, 2022 financial results will be released on Monday, May 2, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 04/19/2022
|
NASDAQ-listed Cardlytics teams up with Crypto.com to provide cashback rewards
- Cryptocurrency exchange Crypto.com has recently announced it has teamed up with Cardlytics, Inc. (NASDAQ: CDLX) to offer cashback rewards to.
- 04/04/2022
|
Analysts Remain Bullish On Cardlytics Post Q4 Results
- Analysts reiterated a Buy on Cardlytics Inc (NASDAQ: CDLX) post Q4 results. Craig-Hallum analyst Jason Kreyer lowered the firm's price target on Cardlytics from $100 to $70 (15% upside) and kept a Buy.
- 03/02/2022
|
Cardlytics (CDLX) Reports Q4 Loss, Tops Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of 63.41% and 16.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/01/2022
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q4 2021 Results - Earnings Call Transcript
- Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q4 2021 Results - Earnings Call Transcript
- 03/01/2022
|
Cardlytics (CDLX) Soars 6.2%: Is Further Upside Left in the Stock?
- Cardlytics (CDLX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 01/13/2022
|
Cardlytics to Present at the 24th Annual Needham Growth Conference
- ATLANTA, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced it will present at the 24th Annual Needham Growth Conference.
- 01/06/2022
|
Why Did Cardlytics Shares Pop 11% Today?
- Craig-Hallum analyst Jason Kreyer lowered the price target on Cardlytics Inc (NASDAQ: CDLX) to $100 from $120, implying a 25.4% upside, and reiterated a Buy. While broader macro concerns over supply chain issues and corresponding labor shortages have been widely topical over the past month, Cardlytics cited these headwinds a quarter ago, reset expectations, and is now working through this new paradigm, the analyst contends.
- 11/03/2021
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q3 2021 Results - Earnings Call Transcript
- Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q3 2021 Results - Earnings Call Transcript
- 11/02/2021
|
Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of 34.00% and 4.14%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/02/2021
|
Cardlytics Announces Timing of Its Third Quarter 2021 Financial Results Conference Call and Webcast
- ATLANTA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced that its third quarter ended September 30, 2021 financial results will be released on Tuesday, November 2, 2021, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 10/19/2021
|
Cardlytics Appoints Microsoft Cloud Chief Financial Officer Chris Suh to Board of Directors
- ATLANTA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), a digital advertising platform, today announced the appointment of Chris Suh, corporate vice president and CFO, Cloud+ AI Group at Microsoft, to its Board of Directors and Audit Committee.
- 09/28/2021
|
Bear of the Day: Cardlytics (CDLX)
- Bulls do damage control after poor earnings guide.
- 08/30/2021
|
New Strong Sell Stocks for August 27th
- CDLX, UUUU, IVC, PSTX, and CYTK have been added to the Zacks Rank #5 (Strong Sell) List on August 27, 2021
- 08/27/2021
|
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Cardlytics investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securitie
- 08/04/2021
|
Cardlytics Stock Gets Decimated on Weak Q2 Sales
- The post Cardlytics Stock Gets Decimated on Weak Q2 Sales appeared first on Millennial Money. Shares of Cardlytics (NASDAQ: CDLX) plunged today after reporting second quarter earnings on Tuesday evening. The company, which operates rewards programs for financial institutions as well as a digital advertising platform, missed revenue expectations and offered a lackluster outlook for the third quarter. As of 12:30 p.m. EDT, Cardlytics stock was down by 26%. The
- 08/04/2021
|
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cardlytics, Inc. (CDLX) on Behalf of Investors
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ: CDLX) investors concerning the Company's possible violations of federal securities laws. On August 3, 2021, after the market closed, Cardlytics announced its second quarter 2021 financial results in a press release. The Company reported revenue of $58.9 million, billings of $85.3 million, and adjusted contribution of $29.6 million, whic
- 08/04/2021
|
Why Cardlytics Is Plunging 25% Today
- Investors are punishing this small company for quarterly results that shouldn't be all that surprising.
- 08/04/2021
|
Cardlytics: A Buying Opportunity
- Cardlytics: A Buying Opportunity
- 08/04/2021
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q2 2021 Results - Earnings Call Transcript
- Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q2 2021 Results - Earnings Call Transcript
- 08/03/2021
|
Cardlytics (CDLX) Reports Q2 Loss, Lags Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of -11.43% and -6.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/03/2021
|
Cardlytics shares plunge 23% on Q2 results
- Shares of Cardlytics Inc. were clobbered in extended trading Tuesday, plunging 23% after the digital-advertising platform reported fiscal second-quarter results. Cardlytics reported a net loss of $47.3 million, or $1.43 a share, compared with a net loss of $19.8 million, or 73 cents a share, in the year-ago quarter.
- 08/03/2021
|
Cardlytics Announces Second Quarter 2021 Financial Results
- ATLANTA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the second quarter ended June 30, 2021. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/.
- 08/03/2021
|
Cardlytics Announces Timing of Its Second Quarter 2021 Financial Results Conference Call and Webcast
- ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced that its second quarter ended June 30, 2021 financial results will be released on Tuesday, August 3, 2021, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
- 07/20/2021
|
Major upside could be in store for these stocks, according to Wall Street's best-performing analysts
- TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Chewy & Square.
- 06/20/2021
|
Cardlytics Announces Peter Chan as Chief Technology Officer
- Former Amazon and Yahoo Executive With 20+ Years in Advertising Tech Experience Leads Cardlytics' Ad Platform Evolution
- 06/07/2021
|
Cardlytics to Present at the BofA Securities 2021 Global Technology Conference
- ATLANTA, June 02, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced it will present at the BofA Securities 2021 Global Technology Conference.
- 06/02/2021
|
Cardlytics to Host Virtual Investor Day on June 10
- ATLANTA, May 18, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, announced today that it will host a virtual Investor Day on Thursday, June 10, 2021.The company's executive team is scheduled to begin presentations at 9:30 a.m. ET. Presenting executives include:
- 05/18/2021
|
Cardlytics to Present at the 16th Annual Needham Virtual Technology & Media Conference
- ATLANTA, May 14, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), one of the largest digital advertising platforms, today announced it will present at the 16th Annual Needham Virtual Technology & Media Conference.
- 05/14/2021
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q1 2021 Results - Earnings Call Transcript
- Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q1 2021 Results - Earnings Call Transcript
- 05/04/2021
|
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of -21.43% and 2.04%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2021
|
CDLX Stock: 13.91% Increase Explanation
- The stock price of Cardlytics Inc (NASDAQ: CDLX) increased by 13.91%. This is why it happened.
- 04/14/2021
|
NovoCure, Synchrony, Twitter, Yum! and More Wednesday Afternoon Analyst Calls
- With the trading day about halfway over, the broad markets were again somewhat mixed.
- 04/14/2021
|
Cardlytics To Acquire Data Platform Bridg For $350M
- Cardlytics Inc (NASDAQ: CDLX) announced its intent to acquire customer data platform Bridg for $350 million in cash to expand Cardlytics' advertising platform with Bridg's SKU-level insights and consumer engagement capabilities across other digital platforms. Additionally, Cardlytics has agreed to two potential earnout payments in cash and stock worth $100 million to $300 million on the first and second year of the closing based on Bridg's U.S. annualized revenue run rate.
- 04/13/2021
|
Cardlytics (CDLX) Buying Bridg For $350 Million
- Cardlytics (NASDAQ: CDLX) announced today that it is going to buy Bridg for approximately $350 million in cash at closing. These are the details.
- 04/13/2021
|
Cardlytics to Acquire Bridg to Accelerate Transformational Growth
- Marketers Will Gain Unprecedented Ability to Understand and Reach Consumers with Bridg SKU Data and Cardlytics' Advertising Platform Marketers Will Gain Unprecedented Ability to Understand and Reach Consumers with Bridg SKU Data and Cardlytics' Advertising Platform
- 04/13/2021
|
Top Stocks To Short Today As Nasdaq Pops Again
- Just as quickly as Nasdaq NDAQ hit correction territory twice in the last week, it saw sharp gains. Meanwhile, Q.ai's deep learning algorithms have brought you today's top shorts.
- 03/11/2021
|
Today's Top Shorts As Tech Stocks Lag With More Rising Bonds
- Bond yields are rising again, crushing tech stocks. But the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts for today.
- 03/03/2021
|
Cardlytics Announces Pricing of Public Offering of Common Stock
- ATLANTA, March 02, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock, at a price to the public of $130.00 per share. The gross proceeds to Cardlytics from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $500.5 million. The offering is expected to close on or about March 5, 2021, subject to customary closing conditions. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 577,500 shares of common stock at the public offering price, less underwriting discounts and commissions.
- 03/02/2021
|
Cardlytics Announces Launch of Offering of $500 million of Shares of Common Stock
- ATLANTA, March 01, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that it has commenced an underwritten public offering of $500 million of shares of common stock. All of the shares of common stock to be sold in the offering will be offered by Cardlytics. In addition, Cardlytics expects to grant the underwriters a 30-day option to purchase up to an additional $75 million of shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- 03/01/2021
|
Cardlytics Acquires Dosh To Expand Digital Ads Platform
- Digital advertising platform Cardlytics plans to acquire Dosh, an advertising platform that offers cash-back rewards, for $275 million in a combined cash and stock deal. The deal should close later in the second quarter.
- 03/01/2021
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q4 2020 Results - Earnings Call Transcript
- Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q4 2020 Results - Earnings Call Transcript
- 03/01/2021
|
Cardlytics Beats Q4 Revenue Estimates, Issues Cautious FY21 Guidance
- Cardlytics Inc (NASDAQ: CDLX) reported the fourth quarter of FY20 a revenue decline of 3.2% year-on-year to $67.1 million, beating analyst estimates of $60.89 million. Average FI MAUs (FI monthly active users) rose 22.6% to 163.6 million.
- 03/01/2021
|
Cardlytics: Q4 Earnings Insights
- Shares of Cardlytics (NASDAQ:CDLX) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share decreased 127.78% year over year to ($0.05), which missed the estimate of ($0.03).
- 03/01/2021
|
Cardlytics Announces Fourth Quarter and Fiscal Year 2020 Financial Results
- ATLANTA, March 01, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, today announced financial results for the fourth quarter and fiscal year ended December 31, 2020. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/.
- 03/01/2021
|
Cardlytics to Acquire Dosh to Bolster Digital Advertising Offering
- ATLANTA, March 01, 2021 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), a digital advertising platform, announced today its planned acquisition of Dosh, a cash-back offers platform, for $275 million in cash and stock.
- 03/01/2021
|
Cardlytics to Present at the Raymond James 42nd Annual Institutional Investors Conference and the 2021 Truist Securities Technology, Internet & Services Conference
- ATLANTA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced it will present at two upcoming conferences: the Raymond James 42nd Annual Institutional Investors Conference and the 2021 Truist Securities Technology, Internet & Services Conference.
- 02/24/2021
|
Cardlytics Announces Timing of Its Fourth Quarter and Fiscal Year 2020 Financial Results Conference Call and Webcast
- ATLANTA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its fourth quarter and fiscal year ended December 31, 2020 financial results will be released on Monday, March 1, 2021, before market open. The company will host a conference call and webcast at 8:00 AM (ET) / 5:00 AM (PT) to discuss the company's financial results.
- 02/16/2021
|
Short-Squeeze Stocks Are a Great Way to Score 10X Gains. Here's a Better Way
- GME stock's meteoric rise is proof that short squeeze stocks are a great way to score 10X gains. But we have an even better way.
- 01/27/2021
|
Cardlytics to Present at the 23rd Annual Needham Virtual Growth Conference
- ATLANTA, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced it will present at the 23rd Annual Needham Virtual Growth Conference.
- 01/06/2021
|
Cardlytics (NASDAQ: CDLX) Files Form 8-K Announcing Multi-Year Contract Renewal with Lloyds Bank Plc
- ATLANTA, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks' digital channels, today filed Form 8-K with the SEC, announcing a multi-year contract renewal with Lloyds Bank Plc.
- 12/16/2020
|
3 More Stocks That Could Benefit In 2021 From Apple's Move to End User Activity Tracking
- If app and device activity tracking is dying, these three companies could be big beneficiaries.
- 12/16/2020
|
Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q3 2020 Results - Earnings Call Transcript
- Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q3 2020 Results - Earnings Call Transcript
- 11/02/2020
|
Cardlytics (CDLX) Reports Q3 Loss, Tops Revenue Estimates
- Cardlytics (CDLX) delivered earnings and revenue surprises of 42.86% and 17.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
- 11/02/2020
|
Cardlytics Announces Third Quarter 2020 Financial Results
- ATLANTA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced financial results for the third quarter ended September 30, 2020. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/.
- 11/02/2020
|
Cardlytics (CDLX) – Research Analysts’ Weekly Ratings Changes
- A number of firms have modified their ratings and price targets on shares of Cardlytics (NASDAQ: CDLX) recently: 10/13/2020 – Cardlytics was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating. 10/6/2020 – Cardlytics was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According […]
- 10/20/2020
|
Charles Schwab Investment Management Inc. Has $10.45 Million Holdings in Cardlytics Inc (NASDAQ:CDLX)
- Charles Schwab Investment Management Inc. grew its holdings in Cardlytics Inc (NASDAQ:CDLX) by 33.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 149,266 shares of the company’s stock after purchasing an additional 37,037 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately […]
- 10/04/2020
|
Tracking Chase Coleman's Tiger Global Portfolio - Q2 2020 Update
- Chase Coleman’s 13F portfolio value increased from $16.61B to $25.79B this quarter. Tiger Global added CrowdStrike Holdings and increased Salesforce.com during the quarter.
- 09/10/2020
|
What Insiders Have To Say About This All-Time High - August 2020 Insider Update
- Insider activity is very informative to follow up for two reasons: it can help predict future market movements and it can be interesting to find undervalued stocks.
- 09/05/2020
|
Cardlytics: Time To Get Out
- Shares of Cardlytics are up ~34% year-to-date and near all-time highs despite mixed performance. Though the company has done a good job of signing on new banks to its platform and adding users, revenue has suffered as marketers pulled back offers.
- 08/26/2020
|
Virtu Financial LLC Purchases Shares of 4,647 Cardlytics Inc (NASDAQ:CDLX)
- Virtu Financial LLC acquired a new stake in shares of Cardlytics Inc (NASDAQ:CDLX) during the second quarter, according to its most recent disclosure with the SEC. The fund acquired 4,647 shares of the company’s stock, valued at approximately $325,000. A number of other hedge funds and other institutional investors have also recently added to or […]
- 08/25/2020
|
We're Interested To See How Cardlytics (NASDAQ:CDLX) Uses Its Cash Hoard To Grow
- Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- 08/12/2020
|
Are Investors Undervaluing Cardlytics, Inc. (NASDAQ:CDLX) By 35%?
- In this article we are going to estimate the intrinsic value of Cardlytics, Inc. (NASDAQ:CDLX) by taking the expected...
- 08/12/2020
|
Scott D. Grimes Sells 2,000 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) Chairman Scott D. Grimes sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $70.19, for a total transaction of $140,380.00. Following the completion of the sale, the chairman now owns 225,166 shares in the company, valued […]
- 08/09/2020
|
10 Small-Cap Stocks Ready to Become Large Caps
- Small-cap stocks have taken some serious punishment in 2020. The S&P SmallCap 600 Index is sporting a year-to-date total return of -11.8%, well short of the S&P 500's total YTD return of 3.0%.Small-cap portfolio managers, especially those that lean heavily on value, are chomping at the bit, waiting for the next leg up. Technical analyst Jonathan Krinsky believes that outperformance could come as soon as this month."They've gone nowhere for two weeks. They've gone nowhere, really, for two years, and there's a lot of actually technology and high-beta names in there that I think can work," Krinsky said August 3 on CNBC's Halftime Report show. "I think small caps are an obvious rotation beneficiary as we push into August."InvestorPlace - Stock Market News, Stock Advice & Trading TipsWe've seen a lot of chatter recently about a few stocks driving the markets -- five big tech stocks account for 22% of the S&P 500, the highest concentration in the history of the index -- so, it seems like a good time to go contrarian. * 7 Travel Stocks to Buy Banking On Pent-Up Demand Here are 10 small-cap stocks likely to become large caps: * iRhythm Technologies (NASDAQ:IRTC) * Everbridge (NASDAQ:EVBG) * Alarm.com Holdings (NASDAQ:ALRM) * Cardlytics (NASDAQ:CDLX) * Goosehead Insurance (NASDAQ:GSHD) * Newmark Group (NASDAQ:NMRK) * Fox Factory Holding (NASDAQ:FOXF) * Howard Hughes (NYSE:HHC) * Trex (NYSE:TREX) * Stag Industrial (NYSE:STAG)If you think the big tech stocks are ready for a breather, these 10 small-cap stocks ought to be up for consideration. Small-Cap Stocks to Buy: iRhythm Technologies (IRTC)Source: Shutterstock Investors in iRhythm Technologies, the maker of the Zio wearable heart monitor, got an early Christmas present on August 4 when the Centers for Medicare and Medicaid Services (CMS) proposed new, permanent codes for long-term electrocardiogram (EKG) monitoring.While I wouldn't consider myself anywhere near an expert about the healthcare system, I can see when a change has been made that is positive for a company's growth; With permanent, rather than temporary, codes for reimbursement on its heart-monitoring patches, sales ought to accelerate.Kudos to InvestorPlace contributor Aaron Levitt for recommending IRTC stock in July 2018. Thanks to the latest announcement, the company's stock is up 129% in the two years since.Technically, not a small-cap stock with a $5.1 billion market cap, the S/Mid stock ought to become a large-cap stock very soon. Everbridge (EVBG)Source: iStockphoto Everbridge makes money by providing businesses with a Critical Event Management Platform to help them react faster to critical events such as the novel coronavirus, keeping their staff and assets safe.Like iRhythm, it's more of a Small-Cap/Mid-Cap stock (SMID) rather than a pure small-cap, which by definition, are those companies with market capitalizations between $300 million and $2 billion.That's okay. Investing is about owning small pieces of great companies, not fitting your strategy into a specific sized company.Year to date, the company is having an excellent performance in the markets. It's got a total return of 92.5%. As I write this, Everbridge is readying to report its second-quarter results. In the first quarter, it grew sales by 38% to $58.9 million, ending the quarter with 5,218 global enterprise customers, 15.1% higher from the same quarter in 2019. * 7 Travel Stocks to Buy Banking On Pent-Up Demand While it's still losing money on both a GAAP and a non-GAAP basis, Covid-19 has proven the future is bright for this global software company. Alarm.com Holdings (ALRM)Source: Shutterstock Alarm.com is the high tech version of the traditional residential and commercial alarm company. It utilizes the internet to provide a cloud-based software platform for subscribers to manage their internet-enabled devices. This includes security, video, access control, energy management, etc., from anywhere in the world.On August 5, Alarm.com reported second-quarter earnings that included a 16.4% increase in sales to $141.6 million, along with a 5.4% increase in adjusted EBITDA of $29.2 million. Except for a small disruption in its business due to Covid-19, it continues to fire on all cylinders.That's why InvestorPlace's Joel Baglole recently made ALRM stock one of four Internet of Things (IoT) stock recommendations. Joel highlighted the fact that the global smart security market is expected to grow 24% annually over the next three years to $21 billion.Alarm.com expects to be a big part of this growth. Cardlytics (CDLX)Source: Pavel Kapysh / Shutterstock.com Of all the stocks on my list, Cardlytics is probably the toughest small-cap stock to recommend at the moment, because the pandemic has hit the company's advertising platform quite hard.The company partners with financial institutions to make tailormade offers to their customers based on the data it collects around purchases made by those customers. Almost all of its revenue is generated through its proprietary Cardlytics Direct advertising channel.In the second quarter, Cardlytics saw its revenue fall 42% to $28.2 million. Its billings fell 46% during the quarter to $39.5 million. As a result, on a non-GAAP basis, it lost $10.2 million during Q2 2020, about four times worse than a year earlier.However, there was a positive: Financial institutions saw their monthly active users (MAUs) increase by 31% to 157.2 million. As the world gets back to an average amount of spending, Cardlytics will benefit from this significant uptick in MAUs. * 7 Travel Stocks to Buy Banking On Pent-Up Demand In the meantime, CDLX stock lost about 11% of its value on the news. Can you say "buy on the dip?" Goosehead Insurance (GSHD)Source: Shutterstock While some of the small-cap stocks on this list rely on high-tech products and services to grow their businesses, Goosehead Insurance uses good old-fashion customer service to win over customers.Based in Texas, it is a rapidly growing, independent personal lines insurance agency. This means that its corporate and franchised sales force represents over 100 insurance companies that underwrite personal lines and small commercial lines risks to customers across the country.On July 30, Goosehead reported an outstanding second quarter that included a 54% increase in revenues to $29.9 million and a net income of 19 cents a share, 217% higher than a year earlier.Due to its success over the first half of 2020, the company announced a special dividend of $1.15 a share for shareholders of record as of the close of business August 10. If you're reading this after August 10, don't despair. There will be plenty of capital appreciation over the next few years as it continues to grow its business.GSHD stock has a YTD total return of 157.5%. Newmark Group (NMRK) Click to EnlargeSource: Shutterstock As we get farther down the list of small-cap stocks, the names get a little more familiar to me. Some of them, including Newmark Group, I've recommended before. In May, I included the commercial real estate advisor in a group of 10 penny stocks worth considering under $5. It's gone sideways in the two months since.At the time, I suggested investors would need some patience as the commercial real estate market was expected to take a beating over Covid-19 and a move to working from home.On August 5, Newmark announced its second-quarter results. As expected, revenues fell 30.4% during the quarter to $383.7 million, while adjusted EBITDA declined 59.0% during the quarter to $45.6 million."Despite significantly lower industry transaction volumes in the second quarter, we generated $47 million of cash flow from operations," stated Chief Executive Officer Barry Gosin."We finished the quarter with over $300 million in cash and cash equivalents, nearly $450 million in mortgage servicing rights, and approximately $680 million of expected proceeds from Nasdaq that are not yet reflected on our balance sheet. These significant assets, taken together with Newmark's operating earnings potential, represent a very attractive investment." * 7 Travel Stocks to Buy Banking On Pent-Up Demand Down 67.8% YTD, I couldn't have said it better myself. Fox Factory Holding (FOXF)I've been familiar with Fox Factory for several years for two reasons.First, I'm smitten by sports-related businesses. I don't do any offroading, but for anyone who does, its shocks and forks are top of the line. Secondly, it once was part of Compass Diversified Holdings (NASDAQ:CODI), a holding company I've recommended in the past that spun it off in 2013, for a substantial profit.Unfortunately for CODI, the nature of its business (private equity) required that it exit its ownership at some point. Over the past five years, FOXF stock has generated an annualized total return of 44.0%, four times the entire U.S. market.Up 598% since its IPO in 2013, I expect it will continue to outperform the markets. Buy on a pullback below $100. Howard Hughes (HHC)Source: Shutterstock If you're a business history buff, as I am, Howard Hughes, the man, will always be an intriguing figure.Howard Hughes, the company, got its start in 1950 when the billionaire bought land in Summerlin, Nevada, which ultimately became a master-planned community (MPC).The past year hasn't been an easy time for the real estate company. In October 2019, the company announced a transformation plan that included the CEO and president, both stepping down from their positions. CEO David Weinreb, who had been the chief executive for nine years, was replaced by Paul Layne, the head of its Central Region. The plan including cutting annual operating expenses by $50 million, selling $2 billion in non-core assets, and accelerating the growth of its core MPC assets. * 7 Travel Stocks to Buy Banking On Pent-Up Demand Bill Ackman is chairman and controls 12.
- 08/07/2020
|
Why Cardlytics Stock Plunged Today
- Shares of Cardlytics (NASDAQ: CDLX) have plunged today, down by 11% as of noon EDT, after the company reported second-quarter earnings. The results were mixed compared to analyst expectations. Billings fell 46% to $39.5 million and financial institution monthly active users (FI MAUs) were 157.2 million.
- 08/05/2020
|
Cardlytics, Inc. (CDLX) Q2 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by, and welcome to Cardlytics' second-quarter 2020 financial results call. Before we begin, let me remind everyone that today's discussion will contain forward-looking statements based on our current assumptions, expectations and beliefs, including expectations about future financial performance or results, the anticipated impact of key priorities on driving growth, the launch of US Bank, growth in FI MAUs or monthly active users, future ARPU or average revenue per user, the evolution of our platform to provide self-service and the potential related benefits to us and our clients, the impact of COVID-19 on our business and the economy as a whole, the impact of our Rise, Retain and Return strategy and the sufficiency of our capital structure.
- 08/05/2020
|
Comparing Livongo Health (NASDAQ:LVGO) and Cardlytics (NASDAQ:CDLX)
- Cardlytics (NASDAQ:CDLX) and Livongo Health (NASDAQ:LVGO) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability. Analyst Ratings This is a breakdown of current ratings and target prices for Cardlytics and Livongo […]
- 08/05/2020
|
Cardlytics, Inc. (CDLX) Reports Q2 Loss, Misses Revenue Estimates
- Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 26.92% and -5.21%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2020
|
Cardlytics Announces Second Quarter 2020 Financial Results
- ATLANTA, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced financial results for the second quarter ended June 30, 2020. Supplemental information is available on the Investor Relations section of the Cardlytics' website at http://ir.cardlytics.com/. “Despite the unprecedented environment in which we have been operating since mid-March, we have stayed focused and kept our foot on the accelerator, in terms of executing our plan for long-term revenue growth and profitability,” said Lynne Laube, CEO & Co-Founder of Cardlytics. “Consumer spending recovered throughout the quarter, and despite a slight pause in recent weeks, we are optimistic that we can narrow our year-over-year declines in the second half of 2020. We continue to see encouraging and exciting signs in our business that will support our long-term growth. These include the completed launch of Wells Fargo, which expands our reach to more than 150 million MAUs, as well as the extensive progress on our product development initiatives. We are also happy to announce that our self-service and automation platform is now being tested with several agencies. For these reasons, we believe we are extraordinarily well positioned over the long-term as the economy continues its recovery.”"We remain committed to achieving our long-term goals and increasing shareholder value,” said Andy Christiansen, CFO of Cardlytics. “Our current capitalization and liquidity will provide us the financial flexibility to weather the economic downturn triggered by COVID-19 and continue with prudent, strategic investments.”Second Quarter 2020 Financial Results * Revenue was $28.2 million, a decrease of (42)% year-over-year, compared to $48.7 million in the second quarter of 2019. * Billings, a non-GAAP metric, was $39.5 million, a decrease of (46)% year-over-year, compared to $73.8 million in the second quarter of 2019. * Gross profit was $7.9 million, a decrease of (55)% year-over-year, compared to $17.7 million in the second quarter of 2019. * Adjusted contribution, a non-GAAP metric, was $12.4 million, a decrease of (43)% year-over-year, compared to $21.8 million in the second quarter of 2019. * Net loss attributable to common stockholders was $(19.8) million, or $(0.73) per diluted share, based on 27.1 million weighted-average common shares outstanding, compared to a net loss attributable to common stockholders of $(6.5) million, or $(0.29) per diluted share, based on 22.7 million weighted-average common shares outstanding in the second quarter of 2019. * Non-GAAP net loss was $(10.2) million, or $(0.38) per diluted share, based on 27.1 million weighted-average common shares outstanding, compared to a non-GAAP net loss of $(2.7) million, or $(0.12) per diluted share, based on 22.7 million weighted-average common shares outstanding in the second quarter of 2019. * Adjusted EBITDA, a non-GAAP metric, was a loss of $(7.7) million compared to a loss of $(0.6) million in the second quarter of 2019.Key Metrics * FI MAUs were 157.2 million, an increase of 31%, compared to 120.1 million in the second quarter of 2019. * ARPU was $0.18, a decrease of (55)%, compared to $0.40 in the second quarter of 2019.Definitions of FI MAUs and ARPU are included below under the caption “Non-GAAP Measures and Other Performance Metrics.”Earnings Teleconference InformationCardlytics will discuss its second quarter 2020 financial results during a teleconference today, August 4, 2020, at 5:00 PM ET / 2:00 PM PT. The conference call can be accessed at (866) 385-4179 (domestic) or (210) 874-7775 (international), conference ID 4382929. A replay of the conference call will be available through 8:00 PM ET / 5:00 PM PT on August 11, 2020 at (855) 859-2056 (domestic) or (404) 537-3406 (international). The replay passcode is 4382929. The call will also be broadcast simultaneously at http://ir.cardlytics.com/. Following the completion of the call, a recorded replay of the webcast will be available on Cardlytics’ website.About CardlyticsCardlytics (NASDAQ: CDLX) is an advertising platform in banks' digital channels. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco, and Visakhapatnam. Learn more at www.cardlytics.com.Cautionary Language Concerning Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to the anticipated impact of COVID-19 on our, business, financial condition and results of operations, our ability to weather the economic downturn triggered by COVID-19 and continue with strategic investments, and narrowing year-over-year declines in the second half of 2020. These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control.Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: risks related to the uncertain impacts that COVID-19 may have on our business, financial condition, results of operations; unfavorable conditions in the global economy and the industries that we serve; our quarterly operating results have fluctuated and may continue to vary from period to period; our ability to sustain our revenue growth and billings; risks related to our substantial dependence on our Cardlytics Direct product; risks related to our substantial dependence on JPMorgan Chase Bank, National Association (“Chase”), Bank of America, National Association ("Bank of America") and a limited number of other financial institution (“FI”) partners; the timing of the phased launch of Cardlytics Direct by U.S. Bank; risks related to our ability to maintain relationships with Chase, Wells Fargo and Bank of America; the amount and timing of budgets by marketers, which are affected by budget cycles, economic conditions and other factors, including the impact of the COVID-19 pandemic; our ability to generate sufficient revenue to offset contractual commitments to FIs; our ability to attract new FI partners and maintain relationships with bank processors and digital banking providers; our ability to maintain relationships with marketers; our ability to adapt to changing market conditions, including our ability to adapt to changes in consumer habits, negotiate fee arrangements with new and existing FIs and retailers, and develop and launch new services and features; and other risks detailed in the “Risk Factors” section of our Form 10-K filed with the Securities and Exchange Commission on March 3, 2020 and in subsequent periodic reports that we file with the Securities and Exchange Commission, including our Form 10-Q for the quarter ended June 30, 2020. Past performance is not necessarily indicative of future results.The forward-looking statements included in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.Non-GAAP Measures and Other Performance MetricsTo supplement the financial measures presented in our press release and related conference call or webcast in accordance with generally accepted accounting principles in the United States (“GAAP”), we also present the following non-GAAP measures of financial performance: billings, adjusted contribution, adjusted EBITDA, adjusted FI Share and other third party costs, non-GAAP loss and non-GAAP loss per share as well as certain other performance metrics, such as FI monthly active users (“FI MAUs”) and average revenue per user (“ARPU”).A “non-GAAP financial measure” refers to a numerical measure of our historical or future financial performance or financial position that is included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP in our financial statements. We provide certain non-GAAP measures as additional information relating to our operating results as a complement to results provided in accordance with GAAP. The non-GAAP financial information presented herein should be considered in conjunction with, and not as a substitute for or superior to, the financial information presented in accordance with GAAP and should not be considered a measure of liquidity. There are significant limitations associated with the use of non-GAAP financial measures.
- 08/04/2020
|
Cardlytics Appoints OpenTable Chief Marketing Officer Jessica Jensen to Board of Directors
- ATLANTA, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced the appointment of OpenTable’s Chief Marketing Officer, Jessica Jensen, to its Board of Directors. Recently elevated to CMO from her position as SVP Marketing, Jensen leads global marketing for the online restaurant-reservation service company. Prior to the coronavirus pandemic, Jensen led growth in customer acquisition on the OpenTable platform. Her current focus is helping customers regain confidence in the food service industry and embrace dining and travel again.Before joining OpenTable, Jensen was the CMO of subscription meal delivery service Sunbasket. Prior to Sunbasket, she led global positioning, marketing strategy, and communications for Facebook as their Head of Products, Platforms, and Insights on the B2B front from 2014 to 2019. Previously, Jensen was Global Head of Product Marketing for iAd, a division of Apple, where she oversaw product development and marketing of the iAd mobile advertising suite. Preceding her time at Apple, she was Vice President of Lifestyles within the U.S. Media Group of Yahoo!.“Along with her expertise in the digital marketing arena, Jessica brings an engrained passion for restaurants and travel,” said Lynne Laube, CEO and co-founder of Cardlytics. “Jessica’s deep understanding of the advertising industry will give us invaluable insight as we evolve our platform.”About Cardlytics Cardlytics (NASDAQ: CDLX) is an advertising platform in banks’ digital channels. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco and Visakhapatnam. Learn more at www.cardlytics.com.PR Contact: ICR \- cardlyticspr@icrinc.com
- 08/04/2020
|
First Trust Advisors LP Buys Shares of 72,948 Cardlytics Inc (NASDAQ:CDLX)
- First Trust Advisors LP bought a new stake in Cardlytics Inc (NASDAQ:CDLX) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 72,948 shares of the company’s stock, valued at approximately $5,105,000. First Trust Advisors LP owned about 0.27% of Cardlytics at the end of […]
- 08/04/2020
|
Cardlytics Hires Farrell Hudzik as Executive Vice President, Financial Institutions
- Hudzik will lead Cardlytics’ Bank Partner Relationships Serving 150M+ Monthly Active UsersATLANTA, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, is growing its bank leadership team with the addition of Farrell Hudzik as Executive Vice President, Financial Institutions. Hudzik will focus on evolving and differentiating the Cardlytics program for all participating U.S. financial institutions. She will also help to further integrate the platform within the banks beyond their respective offers’ programs. “As our platform continues to grow, we’re focused on helping our bank partners deliver even more value to their customers, while driving spend and overall loyalty,” said Cardlytics CEO and co-founder, Lynne Laube. “We’re thrilled to welcome Farrell, whose extensive background and expertise in helping banks maximize the value of their programs will prove instrumental for our partners.”Hudzik joins Cardlytics from Synchrony where she was Senior Vice President, Enterprise Customer Engagement. In that role, she was responsible for developing and leading Synchrony's first Customer Experience Design and Insights Team. Previously, Hudzik was Managing Director at Accenture Interactive leading their Global Loyalty and Rewards Practice. Prior to joining Accenture, Hudzik was Vice President, Financial Services and Global Alliance Executive at Epsilon where she focused on delivering solutions and expanding relationships with clients in financial services.About Cardlytics Cardlytics (NASDAQ: CDLX) is an advertising platform in banks’ digital channels. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco and Visakhapatnam. Learn more at www.cardlytics.com.PR Contact: ICR - cardlyticspr@icrinc.com
- 08/03/2020
|
David Evans, Chief Administrative Officer, announces retirement from Cardlytics
- ATLANTA, July 29, 2020 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, announced today that David Evans, chief administrative officer and former chief financial officer, will retire from the Company at the end of the quarter after six years, including four as CFO. Evans helped drive Cardlytics’ transformation from an emerging technology company into a leading digital marketing platform. “On behalf of the company and the Board of Directors, I want to thank David for his six years of exemplary service to Cardlytics,” said Scott Grimes, Cardlytics co-founder and executive chairman. “David was instrumental in developing and executing the company’s strategy that helped position us as a leader in our market.” Lynne Laube, Cardlytics co-founder and CEO added, “David was an incredible partner as we completed our IPO in 2018, and since then has helped guide Cardlytics as a public company. He has been a strategic and valued partner to our business leaders, and I appreciate his support in my recent transition to CEO.” Evans added, “I would like to thank the Board, Scott and Lynne, and the talented team at Cardlytics. It was an honor and a privilege to work alongside such a fine group of individuals and I am grateful for the six exciting and impactful years at the company.” About Cardlytics Cardlytics (NASDAQ: CDLX) is an advertising platform in banks’ digital channels. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco and Visakhapatnam. Learn more at www.cardlytics.com.Contacts:Public Relations: ICR cardlyticspr@icrinc.com
- 07/29/2020
|
Earnings Preview: Cardlytics, Inc. (CDLX) Q2 Earnings Expected to Decline
- Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/28/2020
|
Ziegler Capital Management LLC Purchases 24,985 Shares of Cardlytics Inc (NASDAQ:CDLX)
- Ziegler Capital Management LLC grew its stake in Cardlytics Inc (NASDAQ:CDLX) by 36.9% in the second quarter, HoldingsChannel.com reports. The fund owned 92,712 shares of the company’s stock after acquiring an additional 24,985 shares during the period. Ziegler Capital Management LLC’s holdings in Cardlytics were worth $6,488,000 at the end of the most recent quarter. […]
- 07/27/2020
|
Cardlytics Expands Advertising Platform with the Launch of My Wells Fargo Deals
- Partnership increases scale to surpass 150 million monthly active usersATLANTA, July 22, 2020 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, announces the launch of My Wells Fargo Deals, a new rewards and loyalty program for the fourth largest bank in the U.S. Through My Wells Fargo Deals, customers can activate offers to earn cash back on everyday purchases, with targeted digital marketing designed to drive incremental in-store and online sales for merchant partners. With insights into more than $3 trillion in annual consumer spend, the Cardlytics launch of My Wells Fargo Deals significantly increases the platform’s scale and ability to reach bank customers in a secure, brand safe channel. This annual consumer spend represents one out of every two credit and debit transactions in the U.S.“Our partnership with Wells Fargo further increases our platform’s reach to compete with the major players in the advertising space, helping brands reach consumers in a trusted, secure channel,” said Lynne Laube, CEO and co-founder of Cardlytics. “Through our valued bank partnerships, we are able to provide marketers a view into nearly $6 million in spend every minute. This gives us incredible insight to shape their marketing strategies and drive purchases from the consumers who are most likely to buy.”Having strong relationships with leading marketers across a variety of industries, Cardlytics has driven more than $33 billion in measurable sales for marketers while giving nearly $500 million back to consumers through these cash back rewards.“We know that consumers today are increasingly looking for ways they can save money while receiving more value for their everyday spending,” said Adam Vancini, head of deposit payments for Wells Fargo’s Deposit Products Group. “Partnering with Cardlytics on this new offering allows us to provide our customers with personalized, cash-back deals from merchants across the U.S. It also enables us to provide some of the top consumer brands a platform to reach customers at a time when they are already thinking about their finances.”For more information on Cardlytics, visit cardlytics.com.About CardlyticsCardlytics (NASDAQ: CDLX) uses purchase intelligence to make marketing more relevant and measurable. We partner with financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships. In turn, we have a secure view into where and when consumers are spending their money. We use these insights to help marketers identify, reach, and influence likely buyers at scale, as well as measure the true sales impact of marketing campaigns. Headquartered in Atlanta, Cardlytics has offices in London, New York, San Francisco and Visakhapatnam. Learn more at www.cardlytics.com.PR Contact: ICR - cardlyticspr@icrinc.com
- 07/22/2020
|
Cardlytics Announces Timing of Its Second Quarter 2020 Financial Results Conference Call and Webcast
- ATLANTA, July 21, 2020 -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that its second quarter ended June 30, 2020.
- 07/21/2020
|
Did Hedge Funds Make The Right Call On Cardlytics, Inc. (CDLX) ?
- How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]
- 07/13/2020
|
JDP Capital Management 2020 Half Year Letter
- Founded in 2011, JDP Capital Management is an investment manager that invests in publicly traded businesses that are often out-of-favor, distressed, or undergoing a significant growth transition.
- 07/10/2020
|
Cardlytics Hires Peter Davies as Head of Sales Strategy and Operations
- ATLANTA, July 09, 2020 -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, is enhancing its leadership team with the addition of industry.
- 07/09/2020
|
Precious metals, biotech among second-quarter fund winners as markets rebounded
- Funds that rode the market's rally to generate the highest second-quarter returns included those invested in assets such as mining stocks, energy and technology.
- 06/30/2020
|
Precious metals, biotech among second-quarter fund winners as markets rebounded
- An overwhelming number of funds generate a positive return over the last three months
- 06/30/2020
|
Graphic - Precious metals, biotech among second-quarter fund winners as markets rebounded
- Graphic - Precious metals, biotech among second-quarter fund winners as markets rebounded
- 06/30/2020
|
V&M Premium Portfolio: 2020 Mid-Year Report Card Through Week 26
- The Premium Portfolio is up +14.43% YTD, while the benchmark S&P 500 Index is down -6.86% through June 26th. The Premium Portfolio has beaten the S&P 500 every
- 06/29/2020
|
Cardlytics Inc (NASDAQ:CDLX) Director John L. Jr. Klinck Sells 5,952 Shares
- Cardlytics Inc (NASDAQ:CDLX) Director John L. Jr. Klinck sold 5,952 shares of Cardlytics stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $84.92, for a total value of $505,443.84. Following the completion of the transaction, the director now owns 21,038 shares of the company’s stock, […]
- 06/10/2020
|
Hedge Funds Still Bullish On Cardlytics, Inc. (CDLX)
- We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]
- 06/08/2020
|
Cardlytics to Present at the Bank of America 2020 Global Technology Conference and the William Blair 40th Annual Growth Stock Conference
- Cardlytics, Inc., (CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, today announced it will present at two upcoming conferences: the Bank of America 2020 Global Technology Conference and the William Blair 40th Annual Growth Stock Conference. Chief Executive Officer and Co-Founder, Lynne Laube, will present at the Bank of America Conference on Thursday, June 4, 2020 at 1:45 p.m. Eastern Time and will be webcast live. Ms. Laube will present at the William Blair Conference on Tuesday, June 9, 2020 at 9:40 a.m. Eastern Time and will be webcast live.
- 05/28/2020
|
5 Stocks to Buy With Heavy Insider Buying in May
- [Editor's Note: "5 Stocks to Buy With Heavy Insider Buying" is regularly updated to include the most relevant information available.]Over the past several weeks, I have consistently pointed to record-high levels of insider buying as a bullish indicator that it's time for you to start looking for stocks to buy.Why? Two big reasons. Insiders are good at picking bottoms, and they are equally as good at picking winning stocks.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOn the first point, just look at this chart from Bloomberg. Insiders are often early in calling stock market bottoms. But they are seldom wrong. Insiders bought big before the markets turned around in the early 2000s, and before markets bottomed in 2009.On the second point, stocks with heavy insider buying tend to outperform. In an email to InvestorPlace, Andrei Simonov, the chairperson of the Department of Finance at Michigan State University, said, "Insider buying is always a positive signal. Numerous academic papers showed that it is indeed a good signal."One of those academic papers, authored by Nejat Seyhun, a University of Michigan finance professor, showed that stocks with significant insider buying tend to outperform by 5%.With that in mind, let's answer a very important question. What stocks which insiders bought big in May should you be buying right now? * 20 Stocks to Buy If You're Still Betting on America to Thrive Consider these five stocks to buy now, all of which had big insider buying in May: * TransDigm (NYSE:TDG) * Harley-Davidson (NYSE:HOG) * CVS (NYSE:CVS) * Virgin Galactic (NASDAQ:SPCE) * Rent-A-Center (NASDAQ:RCII) Stocks to Buy: TransDigm (TDG)Source: Pavel Kapysh / Shutterstock.com [Note: all insider data is sourced from Finviz.com]As a designer, producer, and supplier of aircraft components, TransDigm has been hit hard amid the novel coronavirus pandemic.Flying demand has screeched to a halt. Against the backdrop of zero demand, airlines aren't ordering new commercial aircraft. TransDigm's commercial aircraft business has been slammed. This pain won't stop anytime soon. TransDigm management is calling for commercial aftermarket sales to drop by 70% to 80% for the rest of the year.But this is a near-term hiccup in what is an otherwise strong growth narrative.Over the next few years, coronavirus fears will fade and economic activity will normalize. Consumers will start flying again. Aircraft component demand will rise again. And TransDigm will get back to growing.All of that is to say that today's dirt-cheap valuation on TDG stock -- 3 times sales versus a five-year-average sales multiple of over 5 -- won't stick around.That's why I'd follow the insiders on this one. Board Director and Managing Director at Berkshire Partners, Robert Small, has bought $125 million worth in May. Fellow Board Director and former CFO of Sherwin-Williams (NYSE:SHW) Sean Hennessy bought $700,00 worth of TDG stock in May.In the long run, those big buys will yield big profits. Harley-Davidson (HOG)Source: Alex Erofeenkov / Shutterstock.com U.S. auto sales have fallen off a cliff as consumers under widespread stay-at-home orders have halted their discretionary spending. This plunge in U.S. auto market demand has caused significant pain for Harley-Davidson.Global retail motorcycle sales at Harley-Davidson dropped more than 20% year-over-year in the first quarter of 2020. HOG stock has dropped nearly 50% year-to-date.The CEO of Harley-Davidson thinks this pain is temporary. On May 8, he bought $2.1 million worth of HOG stock.I think he's right.Over the next few months, the U.S. economy will gradually reopen. As it does, consumer behavior will start to normalize, and discretionary spending will rebound. U.S. auto sales demand will slowly recover. Harley-Davidson's growth trends will improve. HOG stock will bounce back. * 7 Earnings Reports to Watch Next Week In other words, it appears the worst is over for Harley-Davidson. Going forward, things should only get better for both the company and the stock. CVS (CVS)Source: Jonathan Weiss / Shutterstock.com As a brick-and-mortar focused retailer, CVS has exposure to stay-at-home headwinds because consumers simply aren't going out and spending as much money at physical locations as they used to.For that reason, CVS stock has shed 16% this year.But the company just reported strong first-quarter numbers which handily topped expectations and included healthy revenue and operating profit growth. Perhaps more importantly, management reiterated its full-year profit guide on the basis that Covid-19 isn't creating huge financial disruption for the company.Does that mean it's time to buy the dip in CVS stock?I think so. So do insiders. Alan Lotvin, the president of CVS Caremark, bought $315,000 worth of CVS stock in mid-May.Over the next few months, economic activity will gradually normalize and CVS' already resilient growth trajectory will only improve. As it does, CVS stock will rebound back to where it was at the beginning of the year, if not higher. Virgin Galactic (SPCE)Source: Tun Pichitanon / Shutterstock.com Once one of the hottest and most hyped-up stocks in the market, commercial spaceflight company Virgin Galactic has seen the air come of out its wheels over the past few months.Specifically, the coronavirus pandemic has presumably (yet again) delayed the launch of Virgin Galactic's first commercial space flight, which was previously supposed to happen in 2020. Because a lot of the hype surrounding the company was based on its ability to finally commence commercial operations in 2020, this delay has weighed significantly on SPCE stock, which has fallen from $43 to $15 in matter of months.Insiders are buying the dip.Since May 11, four insiders -- including the CEO and COO -- have collectively bought $240,000 worth of SPCE stock.In the long run, those buys will yield big rewards.Virgin Galactic is a pioneer in the commercial space market, which is expected to grow from $350 billion today, to $1.1 trillion by 2040. Over that stretch, Virgin Galactic will turn into a really big company, powered by a niche but high-demand commercial spaceflight business and the development of hypersonic air travel technology (which could be used to replace planes at scale). * 9 Stocks to Buy as People Are Still Stuck at Home In other words, as the space economy booms over the next two decades, SPCE stock will roar higher. Against that long-term backdrop, today's coronavirus-related weakness is nothing more than a buying opportunity. Rent-A-Center (RCII)Source: dennizn / Shutterstock.com Last, but not least, on this list of stocks to buy with heavy insider buying is Rent-A-Center.As a rental equipment retailer, Rent-A-Center was initially seen on Wall Street as a big loser amid the coronavirus pandemic because of physical store closures. RCII stock dropped from $31 in late January, to $12 by March.Then, Wall Street started to think that a discount-focused, rental-oriented equipment retailer like Rent-A-Center may actually win during Covid-19, because tight budgets will push consumers away from buying big-ticket items and towards renting them.Rent-A-Center's first quarter numbers confirmed that this is the case. The company reported positive revenue and comparable sales growth in the quarter, and commented that April sales trends have been quite strong, led by out-sized gains in the e-commerce business.Over the next few months, the economy will gradually re-open (providing support for more consumer discretionary spend). But consumers will be cautious with their spend because of the huge job loss the economy has suffered (thereby providing support for more consumer discretionary spend on discount, rental items).As such, Rent-A-Center's growth trends should only get better as we head into the back-half of 2020. As they do, RCII stock will keep rallying.Insiders apparently agree. In May, two Board Directors purchased nearly $800,000 worth of RCII stock.I say follow those insiders, and stick with this rally for the foreseeable future.Luke Lango is a Markets Analyst for InvestorPlace. He has been professionally analyzing stocks for several years, previously working at various hedge funds and currently running his own investment fund in San Diego. A Caltech graduate, Luke has consistently been recognized as one of the best stock pickers in the world by various other analysts and platforms, and has developed a reputation for leveraging his technology background to identify growth stocks that deliver outstanding returns. Luke is also the founder of Fantastic, a social discovery company backed by an LA-based internet venture firm. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * America's 1 Stock Picker Reveals Next 1,000% Winner * 25 Stocks You Should Sell Immediately * 1 Under-the-Radar 5G Stock to Buy Now * The 1 Stock All Retirees Must Own The post 5 Stocks to Buy With Heavy Insider Buying in May appeared first on InvestorPlace.
- 05/15/2020
|
The Charts of Cardlytics Look Ready for Further Gains
- During the "Lightning Round" segment of Mad Money Thursday night, one caller asked Jim Cramer about Cardlytics : "This looks like the right price to buy into this one," said Cramer. Let's check the charts of this purchase intelligence platform that lets marketers reach consumers in their online and mobile banking channels.
- 05/15/2020
|
Downgrade: Here's How Analysts See Cardlytics, Inc. (NASDAQ:CDLX) Performing In The Near Term
- Today is shaping up negative for Cardlytics, Inc. (NASDAQ:CDLX) shareholders, with the analysts delivering a...
- 05/15/2020
|
Cardlytics: A Continued Rally Will Be Challenging Due To Slowing Growth
- Shares of Cardlytics have shot up more than 30% after the company delivered better-than-expected Q1 earnings results. However, despite a strong increase in MAUs
- 05/13/2020
|
Why Cardlytics Stock Jumped 22%
- Cardlytics (NASDAQ: CDLX), a company that uses purchase information to help marketing providers improve their rewards programs and other customer services, jumped 22% early Tuesday after releasing a solid first-quarter result. Cardlytics' adjusted loss per share checked in at $0.26, worse than the prior year's $0.23 adjusted per-share loss, and wider than analysts' estimates of a $0.21 adjusted per-share loss. "We delivered solid first quarter results, with billings, revenue and adjusted contribution in the upper half of our prior guidance," said Scott Grimes, CEO and co-founder of Cardlytics, in a press release.
- 05/12/2020
|
Cardlytics, Inc. (CDLX) Q1 2020 Earnings Call Transcript
- Ladies and gentlemen, thank you for standing by, and welcome to the First Quarter 2020 Cardlytics, Inc. Earnings Conference Call. With that, let me turn the call over to Scott Grimes, Cardlytics' CEO and Co-Founder.
- 05/12/2020
|
8-K: Cardlytics, Inc.
- (EDGAR Online via COMTEX) --
Document
false0001666071 0001666071 2020-05-11 2020-05-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549...
- 05/12/2020
|
Cardlytics, Inc. (CDLX) CEO Scott Grimes on Q1 2020 Results - Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX) Q1 2020 Earnings Conference Call May 11, 2020, 17:00 ET Company Participants Kirk Somers - Chief Legal & People Officer and S
- 05/12/2020
|
Cardlytics Inc (CDLX) Reports Q1 Loss, Tops Revenue Estimates
- Cardlytics Inc (CDLX) delivered earnings and revenue surprises of -18.18% and 5.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/12/2020
|
Cardlytics Announces First Quarter 2020 Financial Results
- ATLANTA, May 11, 2020 -- Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, today announced financial results.
- 05/11/2020
|
Cardlytics to Present at the J.P. Morgan 48th Annual Global Technology, Media and Communications Conference and the 15th Annual Needham Technology & Media Conference
- ATLANTA, Ga., May 07, 2020 -- Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, today announced it will.
- 05/07/2020
|
The Cardlytics (NASDAQ:CDLX) Share Price Is Up 162% And Shareholders Are Boasting About It
- Cardlytics, Inc. (NASDAQ:CDLX) shareholders might understandably be very concerned that the share price has dropped...
- 05/06/2020
|
10 Small-Cap Stocks to Buy for HUGE Gains in the Next 10 Years
- These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.
- 05/04/2020
|
Aimia Loyalty Solutions and Kognitiv Corporation Merge to Form a Visionary Leader in Loyalty
- TORONTO , April 29, 2020 /CNW Telbec/ - Aimia Inc. (AIM.TO) and Kognitiv Corporation announce that they have entered into an agreement to merge Aimia's Loyalty Solutions business with Kognitiv Corporation. The merger creates a new and transformative technology and loyalty solutions company that redefines how loyalty programs, merchants, and consumer brands interact to enrich member engagement, enhance consumer loyalty and deliver stronger yields to the businesses it serves.
- 04/29/2020
|
Cardlytics Announces Timing of Its First Quarter 2020 Financial Results Conference Call and Webcast
- ATLANTA, April 27, 2020 -- Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, today announced that its first.
- 04/27/2020
|
Cardlytics (NASDAQ:CDLX) Downgraded to Underperform at Bank of America
- Bank of America lowered shares of Cardlytics (NASDAQ:CDLX) from a buy rating to an underperform rating in a research note released on Tuesday morning, Briefing.com Automated Import reports. The firm currently has $26.00 price target on the stock. CDLX has been the topic of a number of other reports. SunTrust Banks cut their price target […]
- 04/25/2020
|
Cardlytics (NASDAQ:CDLX) Upgraded by BidaskClub to "Buy"
- BidaskClub upgraded shares of Cardlytics (NASDAQ:CDLX) from a hold rating to a buy rating in a report released on Tuesday, BidAskClub reports. Several other brokerages also recently commented on CDLX. ValuEngine raised shares of Cardlytics from a sell rating to a hold rating in a research report on Tuesday, March 3rd. Raymond James cut Cardlytics […]
- 04/25/2020
|
Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes Sells 37,500 Shares
- Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 37,500 shares of the stock in a transaction dated Tuesday, April 21st. The stock was sold at an average price of $39.92, for a total value of $1,497,000.00. Following the sale, the chief executive officer now directly owns 301,731 shares in the company, valued at approximately $12,045,101.52. […]
- 04/23/2020
|
Corporate Insiders Pull the Trigger on These 5 Stocks
- Market watchers are looking to the insiders, hoping insights from their activity can steer them towards returns from these stocks to buy.
- 04/22/2020
|
Cardlytics (NASDAQ:CDLX) Trading Down 10.2% Following Insider Selling
- Cardlytics Inc (NASDAQ:CDLX)’s stock price fell 10.2% on Tuesday after an insider sold shares in the company. The company traded as low as $38.00 and last traded at $39.84, 1,435,345 shares were traded during trading. An increase of 67% from the average session volume of 859,246 shares. The stock had previously closed at $44.37. Specifically, […]
- 04/22/2020
|
6 Communication Services Stocks Moving In Tuesday's Pre-Market Session
- Gainers
• Remark Holdings, Inc. (NASDAQ:MARK) shares increased by 5.37% to $0.42 during Tuesday's pre-market session.
• Liberty TripAdvisor Hldgs, Inc. (NASDAQ:LTRPB...
- 04/21/2020
|
Cardlytics Inc (NASDAQ:CDLX) Insider Kirk Somers Sells 2,000 Shares of Stock
- Cardlytics Inc (NASDAQ:CDLX) insider Kirk Somers sold 2,000 shares of the firm’s stock in a transaction on Friday, April 17th. The stock was sold at an average price of $47.71, for a total transaction of $95,420.00. Following the sale, the insider now owns 71,918 shares in the company, valued at $3,431,207.78. The sale was disclosed […]
- 04/21/2020
|
Frontier Capital Management Co. LLC Purchases 135,322 Shares of Cardlytics Inc (NASDAQ:CDLX)
- Frontier Capital Management Co. LLC increased its position in Cardlytics Inc (NASDAQ:CDLX) by 40.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 468,102 shares of the company’s stock after purchasing an additional 135,322 shares during the quarter. Frontier Capital Management […]
- 04/19/2020
|
Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes Sells 37,500 Shares
- Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 37,500 shares of the firm’s stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $43.30, for a total value of $1,623,750.00. Following the completion of the sale, the chief executive officer now directly owns 370,055 shares of the company’s […]
- 04/19/2020
|
Were Hedge Funds Right About Zuora, Inc. (ZUO)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/18/2020
|
Were Hedge Funds Right About LGI Homes Inc (LGIH)?
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 04/18/2020
|
Were Hedge Funds Right About The RealReal, Inc. (REAL)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/18/2020
|
Were Hedge Funds Right About Tronox Limited (TROX)?
- Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to […]
- 04/18/2020
|
Were Hedge Funds Right About Cardlytics, Inc. (CDLX)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/18/2020
|
Alliancebernstein L.P. Sells 2,300 Shares of Cardlytics Inc (NASDAQ:CDLX)
- Alliancebernstein L.P. decreased its stake in shares of Cardlytics Inc (NASDAQ:CDLX) by 12.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,400 shares of the company’s stock after selling 2,300 shares during the period. Alliancebernstein L.P.’s holdings in Cardlytics were worth […]
- 04/18/2020
|
Geode Capital Management LLC Grows Stock Holdings in Cardlytics Inc (NASDAQ:CDLX)
- Geode Capital Management LLC boosted its holdings in shares of Cardlytics Inc (NASDAQ:CDLX) by 14.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 241,141 shares of the company’s stock after purchasing an additional 29,644 shares during the quarter. Geode Capital […]
- 04/18/2020
|
Contrasting Cardlytics (NASDAQ:CDLX) and Phoenix Tree (NASDAQ:LIZI)
- Cardlytics (NASDAQ:CDLX) and Phoenix Tree (NASDAQ:LIZI) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Valuation and Earnings This table compares Cardlytics and Phoenix Tree’s revenue, earnings per share (EPS) […]
- 04/17/2020
|
Can You Imagine How Jubilant Cardlytics’s (NASDAQ:CDLX) Shareholders Feel About Its 193% Share Price Gain?
- The last three months have been tough on Cardlytics, Inc. (NASDAQ:CDLX) shareholders, who have seen the share price...
- 04/16/2020
|
Lynne Marie Laube Sells 50,000 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) COO Lynne Marie Laube sold 50,000 shares of the company’s stock in a transaction on Monday, April 13th. The stock was sold at an average price of $41.58, for a total transaction of $2,079,000.00. Following the sale, the chief operating officer now directly owns 324,302 shares of the company’s stock, valued at […]
- 04/16/2020
|
Cardlytics (NASDAQ:CDLX) Trading Down 6.4% on Insider Selling
- Cardlytics Inc (NASDAQ:CDLX) shares fell 6.4% during trading on Wednesday after an insider sold shares in the company. The company traded as low as $41.72 and last traded at $43.25, 647,882 shares were traded during mid-day trading. A decline of 25% from the average session volume of 863,530 shares. The stock had previously closed at […]
- 04/16/2020
|
Goldman Sachs Group Inc. Sells 62,259 Shares of Cardlytics Inc (NASDAQ:CDLX)
- Goldman Sachs Group Inc. trimmed its position in shares of Cardlytics Inc (NASDAQ:CDLX) by 58.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,502 shares of the company’s stock after selling 62,259 shares during the period. Goldman Sachs Group Inc. owned […]
- 04/13/2020
|
Cardlytics Sees Unusually Large Options Volume (NASDAQ:CDLX)
- Cardlytics Inc (NASDAQ:CDLX) was the recipient of some unusual options trading on Thursday. Investors bought 2,992 put options on the company. This is an increase of 1,064% compared to the average volume of 257 put options. Shares of Cardlytics stock opened at $43.68 on Friday. The stock has a fifty day simple moving average of […]
- 04/11/2020
|
AQR Capital Management LLC Makes New Investment in Cardlytics Inc (NASDAQ:CDLX)
- AQR Capital Management LLC bought a new position in shares of Cardlytics Inc (NASDAQ:CDLX) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 11,060 shares of the company’s stock, valued at approximately $695,000. A number of other institutional investors and hedge funds also recently made changes to their […]
- 04/10/2020
|
Analysts Set Cardlytics Inc (NASDAQ:CDLX) Price Target at $58.60
- Cardlytics Inc (NASDAQ:CDLX) has received an average recommendation of “Hold” from the twelve brokerages that are covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage […]
- 04/09/2020
|
Sen. David Perdue Discloses Buys of Berkshire Hathaway, Starbucks Stock
- The Georgia Republican, whose joint account is managed by a third party, also noted purchases of Micron and Cardlytics stock in March. The account also sold significant amounts of Kroger stock.
- 04/08/2020
|
Cardlytics (NASDAQ:CDLX) PT Lowered to
- Cardlytics (NASDAQ:CDLX) had its target price lowered by equities researchers at SunTrust Banks from to in a research report issued on Monday, The Fly reports. The brokerage presently has a “buy” rating on the stock. CDLX has been the subject of a number of other research reports. BidaskClub lowered Cardlytics from a “buy” rating to […]
- 04/08/2020
|
Cardlytics (NASDAQ:CDLX) Shares Up 26.2% on Insider Buying Activity
- Cardlytics Inc (NASDAQ:CDLX)’s stock price shot up 26.2% during mid-day trading on Monday after an insider bought additional shares in the company. The company traded as high as $38.13 and last traded at $37.51, 1,293,426 shares were traded during mid-day trading. An increase of 51% from the average session volume of 854,466 shares. The stock […]
- 04/07/2020
|
Cardlytics (CDLX) Receives a Buy from SunTrust Robinson
- In a report released today, Youssef Squali from SunTrust Robinson maintained a Buy rating on Cardlytics (CDLX), with a price target of $50.00. The
- 04/06/2020
|
Cardlytics (CDLX) Receives a Buy from SunTrust Robinson
- In a report released today, Youssef Squali from SunTrust Robinson maintained a Buy rating on Cardlytics (CDLX – Research Report),
- 04/06/2020
|
Cardlytics Inc (NASDAQ:CDLX) Major Shareholder Buys $1,473,930.00 in Stock
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin acquired 47,700 shares of the stock in a transaction that occurred on Thursday, April 2nd. The shares were bought at an average price of $30.90 per share, for a total transaction of $1,473,930.00. The purchase was disclosed in a filing with the SEC, which can be accessed through […]
- 04/05/2020
|
Axa Takes Position in Cardlytics Inc (NASDAQ:CDLX)
- Axa bought a new stake in shares of Cardlytics Inc (NASDAQ:CDLX) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,500 shares of the company’s stock, valued at approximately $283,000. Other hedge funds have also made changes to their positions […]
- 04/04/2020
|
Raymond James & Associates Buys Shares of 10,574 Cardlytics Inc (NASDAQ:CDLX)
- Raymond James & Associates bought a new stake in Cardlytics Inc (NASDAQ:CDLX) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 10,574 shares of the company’s stock, valued at approximately $665,000. A number of other hedge funds have also recently added to or reduced their stakes […]
- 04/04/2020
|
Cardlytics (NASDAQ:CDLX) Trading Down 3.3%
- Shares of Cardlytics Inc (NASDAQ:CDLX) fell 3.3% during mid-day trading on Thursday . The company traded as low as $31.71 and last traded at $31.41, 13,994 shares were traded during mid-day trading. A decline of 99% from the average session volume of 1,526,201 shares. The stock had previously closed at $32.47. Several research firms have […]
- 04/04/2020
|
Cardlytics (NASDAQ:CDLX) Rating Lowered to Hold at BidaskClub
- Cardlytics (NASDAQ:CDLX) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, BidAskClub reports. Several other brokerages have also recently weighed in on CDLX. Zacks Investment Research cut Cardlytics from a “strong-buy” rating to a “hold” rating in a report on Monday, […]
- 04/04/2020
|
Clifford Sosin Acquires 50,000 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin bought 50,000 shares of the company’s stock in a transaction on Tuesday, March 31st. The shares were acquired at an average price of $36.52 per share, with a total value of $1,826,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is […]
- 04/04/2020
|
Cardlytics Can Benefit From Online Banking Boost
- Shares of Cardlytics have fallen ~70% from peaks reached in February, amid a strengthening in the company's fundamentals. Prior to the spread of the coronavirus
- 04/02/2020
|
Fly Insider: IFF, Smartsheet among week's notable insider trades IFF;CQP;NGM;PSEC;CDLX;SMAR;XPO;PTON;NXRT;NFLX
- Fly Insider: IFF, Smartsheet among week's notable insider trades IFF CQP NGM PSEC CDLX SMAR XPO PTON NXRT NFLX
- 03/30/2020
|
1,334 Shares in Cardlytics Inc (NASDAQ:CDLX) Acquired by Great West Life Assurance Co. Can
- Great West Life Assurance Co. Can purchased a new position in shares of Cardlytics Inc (NASDAQ:CDLX) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,334 shares of the company’s stock, valued at approximately $83,000. Several other hedge funds have also modified their […]
- 03/30/2020
|
Cardlytics Inc (NASDAQ:CDLX) CEO Sells $416,200.00 in Stock
- Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 25th. The shares were sold at an average price of $41.62, for a total transaction of $416,200.00. Following the sale, the chief executive officer now directly owns 387,631 shares of the company’s stock, […]
- 03/30/2020
|
Insider Buying: Cardlytics Inc (NASDAQ:CDLX) Major Shareholder Acquires $7,400,000.00 in Stock
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin bought 200,000 shares of the stock in a transaction dated Thursday, March 26th. The shares were acquired at an average price of $37.00 per share, with a total value of $7,400,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be […]
- 03/30/2020
|
Cardlytics Inc (NASDAQ:CDLX) Expected to Post Quarterly Sales of $44.27 Million
- Wall Street brokerages predict that Cardlytics Inc (NASDAQ:CDLX) will announce $44.27 million in sales for the current quarter, Zacks reports. Five analysts have made estimates for Cardlytics’ earnings, with the lowest sales estimate coming in at $39.50 million and the highest estimate coming in at $46.20 million. Cardlytics posted sales of $35.99 million during the […]
- 03/29/2020
|
Scott D. Grimes Sells 1,000 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 1,000 shares of the company’s stock in a transaction on Monday, March 23rd. The shares were sold at an average price of $30.52, for a total value of $30,520.00. Following the completion of the sale, the chief executive officer now owns 389,431 shares in the company, valued […]
- 03/28/2020
|
Cardlytics (NASDAQ:CDLX) Stock Price Down 13.7% After Insider Selling
- Shares of Cardlytics Inc (NASDAQ:CDLX) dropped 13.7% during mid-day trading on Friday after an insider sold shares in the company. The company traded as low as $36.95 and last traded at $37.00, approximately 865,006 shares changed hands during trading. An increase of 3% from the average daily volume of 837,068 shares. The stock had previously […]
- 03/28/2020
|
Cardlytics Inc (NASDAQ:CDLX) Expected to Announce Earnings of -$0.24 Per Share
- Brokerages expect that Cardlytics Inc (NASDAQ:CDLX) will post earnings of ($0.24) per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Cardlytics’ earnings, with estimates ranging from ($0.30) to ($0.17). Cardlytics reported earnings per share of ($0.23) during the same quarter last year, which suggests a negative year over […]
- 03/27/2020
|
Algert Global LLC Makes New Investment in Cardlytics Inc (NASDAQ:CDLX)
- Algert Global LLC bought a new position in shares of Cardlytics Inc (NASDAQ:CDLX) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 8,443 shares of the company’s stock, valued at approximately $531,000. A number of other institutional investors also recently made […]
- 03/27/2020
|
Cardlytics (NASDAQ:CDLX) Upgraded by BidaskClub to "Buy"
- Cardlytics (NASDAQ:CDLX) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Friday, BidAskClub reports. Several other brokerages have also commented on CDLX. Craig Hallum lowered Cardlytics from a “buy” rating to a “hold” rating and dropped their price objective for the company from $100.00 […]
- 03/27/2020
|
Daily Insider Ratings Round-Up 3/24/20
- Tables of the top insider purchases and sales filed with the SEC on 3/24/20, based on dollar value. Dollar values often do not equate with significance when it
- 03/26/2020
|
Lynne Marie Laube Sells 5,740 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) COO Lynne Marie Laube sold 5,740 shares of the stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $31.50, for a total value of $180,810.00. Following the completion of the transaction, the chief operating officer now directly owns 336,141 shares in the company, valued […]
- 03/26/2020
|
Clifford Sosin Acquires 181,621 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin acquired 181,621 shares of the stock in a transaction that occurred on Monday, March 23rd. The shares were bought at an average cost of $29.52 per share, with a total value of $5,361,451.92. The acquisition was disclosed in a legal filing with the SEC, which is available through […]
- 03/26/2020
|
Cardlytics (NASDAQ:CDLX) Stock Price Up 34% After Insider Buying Activity
- Shares of Cardlytics Inc (NASDAQ:CDLX) shot up 34% on Tuesday after an insider bought additional shares in the company. The stock traded as high as $40.63 and last traded at $39.51, 1,279,451 shares were traded during trading. An increase of 56% from the average session volume of 817,563 shares. The stock had previously closed at […]
- 03/25/2020
|
Markets Soared Today, The Rally May Continue Wednesday: Fight That Urge To Buy, And Sell Instead
- Emotions get in the way of good trading practice. It shows itself often in our decision process to sell. Why do people have the urge to buy in up markets and se
- 03/25/2020
|
Raymond James Financial Services Advisors Inc. Purchases 5,466 Shares of Cardlytics Inc (NASDAQ:CDLX)
- Raymond James Financial Services Advisors Inc. raised its position in shares of Cardlytics Inc (NASDAQ:CDLX) by 46.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,336 shares of the company’s stock after acquiring an additional 5,466 shares during the period. Raymond […]
- 03/23/2020
|
Daily Insider Ratings Round Up + Daily Ratings Report For 3/20/20
- We're augmenting our usual tables of top 10 dollar value insider purchases and sales filed with the SEC on 3/20/20, with our full Daily Ratings Report for the s
- 03/22/2020
|
Credit Suisse AG Reduces Stock Holdings in Cardlytics Inc (NASDAQ:CDLX)
- Credit Suisse AG lowered its position in Cardlytics Inc (NASDAQ:CDLX) by 16.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 70,115 shares of the company’s stock after selling 13,372 shares during the period. Credit Suisse AG’s holdings in Cardlytics were worth $4,407,000 at the end of the most recent reporting period. Other hedge […]
- 03/22/2020
|
Clifford Sosin Acquires 100,000 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin purchased 100,000 shares of the business’s stock in a transaction that occurred on Thursday, March 19th. The stock was bought at an average price of $30.54 per share, with a total value of $3,054,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
- 03/22/2020
|
Cardlytics Inc (NASDAQ:CDLX) Insider Sells $89,140.00 in Stock
- Cardlytics Inc (NASDAQ:CDLX) insider Kirk Somers sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $44.57, for a total transaction of $89,140.00. Following the transaction, the insider now directly owns 73,918 shares in the company, valued at approximately $3,294,525.26. […]
- 03/21/2020
|
Clifford Sosin Purchases 127,444 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin acquired 127,444 shares of the firm’s stock in a transaction that occurred on Tuesday, March 17th. The shares were bought at an average cost of $44.68 per share, for a total transaction of $5,694,197.92. The purchase was disclosed in a legal filing with the SEC, which is available […]
- 03/21/2020
|
Daily Insider Ratings Round Up 3/19/20
- Tables of the top insider purchases and sales filed with the SEC on 3/19/20, based on dollar value. Dollar values often do not equate with significance when it
- 03/20/2020
|
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Invests $552,000 in Cardlytics Inc (NASDAQ:CDLX)
- BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp purchased a new position in shares of Cardlytics Inc (NASDAQ:CDLX) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,780 shares of the company’s stock, valued at approximately $552,000. Other hedge funds have also modified their holdings of the […]
- 03/19/2020
|
Advisor Group Inc. Has $1.28 Million Stock Position in Cardlytics Inc (NASDAQ:CDLX)
- Advisor Group Inc. lifted its holdings in shares of Cardlytics Inc (NASDAQ:CDLX) by 5,215.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,411 shares of the company’s stock after buying an additional 20,027 shares during the period. Advisor Group Inc. owned about 0.09% of Cardlytics […]
- 03/19/2020
|
Cardlytics Inc (NASDAQ:CDLX) Major Shareholder Clifford Sosin Acquires 79,861 Shares
- Cardlytics Inc (NASDAQ:CDLX) major shareholder Clifford Sosin bought 79,861 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $47.36 per share, with a total value of $3,782,216.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
- 03/17/2020
|
John V. Balen Purchases 1,000 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) Director John V. Balen purchased 1,000 shares of the company’s stock in a transaction on Thursday, March 12th. The stock was purchased at an average cost of $45.00 per share, for a total transaction of $45,000.00. Following the purchase, the director now directly owns 16,021 shares in the company, valued at $720,945. […]
- 03/17/2020
|
Cardlytics (NASDAQ:CDLX) Rating Reiterated by SunTrust Banks
- SunTrust Banks reissued their buy rating on shares of Cardlytics (NASDAQ:CDLX) in a report published on Thursday, AnalystRatings.com reports. The brokerage currently has a $77.00 price objective on the stock. CDLX has been the subject of several other research reports. TheStreet raised Cardlytics from a d rating to a c- rating in a research report […]
- 03/16/2020
|
Cardlytics Inc (NASDAQ:CDLX) Receives $67.60 Average Price Target from Brokerages
- Cardlytics Inc (NASDAQ:CDLX) has been given a consensus rating of “Hold” by the eleven ratings firms that are covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1-year target price among brokerages that have issued […]
- 03/15/2020
|
Bank of Montreal Can Has $1.09 Million Position in Cardlytics Inc (NASDAQ:CDLX)
- Bank of Montreal Can lifted its stake in Cardlytics Inc (NASDAQ:CDLX) by 3.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,314 shares of the company’s stock after purchasing an additional 598 shares during the period. Bank of Montreal […]
- 03/14/2020
|
Insider Selling: Cardlytics Inc (NASDAQ:CDLX) CEO Sells $323,316.40 in Stock
- Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 7,460 shares of the company’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $43.34, for a total value of $323,316.40. Following the completion of the sale, the chief executive officer now directly owns 389,731 shares of […]
- 03/14/2020
|
Cardlytics (NASDAQ: CDLX) Files Form 8-K Announcing U.S. Bank Launch
- ATLANTA, March 13, 2020 -- Cardlytics (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, filed Form 8-K with the SEC this week,.
- 03/13/2020
|
Cardlytics (NASDAQ: CDLX) Files Form 8-K Announcing U.S. Bank Launch
- ATLANTA, March 13, 2020 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and...
- 03/13/2020
|
Kirk Somers Sells 2,788 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) insider Kirk Somers sold 2,788 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $44.64, for a total transaction of $124,456.32. Following the sale, the insider now owns 76,218 shares of the company’s stock, valued at $3,402,371.52. The transaction was […]
- 03/13/2020
|
Lynne Marie Laube Sells 5,109 Shares of Cardlytics Inc (NASDAQ:CDLX) Stock
- Cardlytics Inc (NASDAQ:CDLX) COO Lynne Marie Laube sold 5,109 shares of Cardlytics stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $44.61, for a total value of $227,912.49. Following the sale, the chief operating officer now directly owns 339,941 shares of the company’s stock, valued at approximately […]
- 03/13/2020
|
Have Cardlytics, Inc. (NASDAQ:CDLX) Insiders Been Selling Their Stock?
- Anyone interested in Cardlytics, Inc. (NASDAQ:CDLX) should probably be aware that the Co-Founder, Scott Grimes...
- 03/12/2020
|
SunTrust Robinson Sticks to Its Buy Rating for Cardlytics (CDLX)
- SunTrust Robinson analyst Youssef Squali maintained a Buy rating on Cardlytics (CDLX) today and set a price target of $77.00. The company's shares closed
- 03/12/2020
|
SunTrust Robinson Sticks to Its Buy Rating for Cardlytics (CDLX)
- SunTrust Robinson analyst
Youssef Squali
maintained a
Buy
rating on Cardlytics (
CDLX
–
Research Report
) today and set a price target of
$77.00
. The company’s shares closed last Monday at $45.83.
According to
TipRanks.com
, Squali is a top 100 anal
- 03/12/2020
|
Cardlytics Inc (NASDAQ:CDLX) Shares Purchased by Charles Schwab Investment Management Inc.
- Charles Schwab Investment Management Inc. boosted its holdings in Cardlytics Inc (NASDAQ:CDLX) by 10.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 110,051 shares of the company’s stock after acquiring an additional 10,564 shares during the period. Charles Schwab Investment Management Inc. owned 0.48% of […]
- 03/12/2020
|
Zacks Investment Research Downgrades Cardlytics (NASDAQ:CDLX) to Hold
- Cardlytics (NASDAQ:CDLX) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports. According to Zacks, “Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It […]
- 03/11/2020
|
Brokers Set Expectations for Cardlytics Inc's Q1 2020 Earnings (NASDAQ:CDLX)
- Cardlytics Inc (NASDAQ:CDLX) – William Blair issued their Q1 2020 EPS estimates for Cardlytics in a note issued to investors on Wednesday, March 4th. William Blair analyst C. Shutler anticipates that the company will post earnings of ($0.32) per share for the quarter. William Blair also issued estimates for Cardlytics’ Q2 2020 earnings at ($0.24) […]
- 03/09/2020
|
Tracking Chase Coleman's Tiger Global Portfolio - Q4 2019 Update
- Chase Coleman’s 13F portfolio value decreased from $18.88B to $18.12B this quarter. Tiger Global increased Uber Technologies & Elastic NV while decreasing Sales
- 03/08/2020
|
Cardlytics Inc (NASDAQ:CDLX) Shares Bought by Barclays PLC
- Barclays PLC boosted its holdings in shares of Cardlytics Inc (NASDAQ:CDLX) by 67.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 40,634 shares of the company’s stock after buying an additional 16,350 shares during the quarter. Barclays PLC’s holdings in Cardlytics were worth $2,554,000 at the end of the most recent reporting period. A […]
- 03/06/2020
|
Cardlytics (NASDAQ:CDLX) Shares Gap Down on Analyst Downgrade
- Cardlytics Inc (NASDAQ:CDLX)’s share price gapped down prior to trading on Thursday after JPMorgan Chase & Co. lowered their price target on the stock from $80.00 to $65.00. The stock had previously closed at $48.64, but opened at $54.55. JPMorgan Chase & Co. currently has a neutral rating on the stock. Cardlytics shares last traded […]
- 03/06/2020
|
Cardlytics (NASDAQ:CDLX) Issues Earnings Results, Beats Expectations By $0.14 EPS
- Cardlytics (NASDAQ:CDLX) announced its earnings results on Tuesday. The company reported $0.18 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.04 by $0.14, Briefing.com reports. Cardlytics had a negative net margin of 8.15% and a negative return on equity of 24.09%. The business had revenue of $69.29 million for […]
- 03/05/2020
|
Cardlytics (NASDAQ:CDLX) Upgraded by TheStreet to "C-"
- Cardlytics (NASDAQ:CDLX) was upgraded by equities researchers at TheStreet from a “d” rating to a “c-” rating in a research note issued on Tuesday, TheStreetRatingsTable reports. A number of other research firms also recently issued reports on CDLX. Bank of America reaffirmed an “average” rating and issued a $100.00 target price on shares of Cardlytics […]
- 03/05/2020
|
Cardlytics, Inc. Just Reported, And Analysts Assigned A US$73.40 Price Target
- Shareholders in Cardlytics, Inc. (NASDAQ:CDLX) had a terrible week, as shares crashed 32% to US$54.55 in the week...
- 03/05/2020
|
Cardlytics (NASDAQ:CDLX) Shares Down 36.7% on Analyst Downgrade
- Shares of Cardlytics Inc (NASDAQ:CDLX) fell 36.7% on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from $80.00 to $65.00. JPMorgan Chase & Co. currently has a neutral rating on the stock. Cardlytics traded as low as $53.11 and last traded at $54.55, 5,254,697 shares traded hands during mid-day trading. […]
- 03/05/2020
|
Why Cardlytics Stock Got Demolished Today
- The customer loyalty program operator reported fourth-quarter results and a C-suite shake-up.
- 03/04/2020
|
Fly Intel: Wall Street's top stories at midday GE;UNH;ANTM;CNC;CVS;HUM;MOH;CYH;THC;HPE;CVET;BNFT;ANF;HIIQ;CDLX;OMI
- Fly Intel: Wall Street's top stories at midday GE UNH ANTM CNC CVS HUM MOH CYH THC HPE CVET BNFT ANF HIIQ CDLX OMI
- 03/04/2020
|
Cardlytics, Inc. (CDLX) Q4 2019 Earnings Call Transcript
- CDLX earnings call for the period ending December 31, 2019.
- 03/04/2020
|
What Makes Cardlytics, Inc. (CDLX) a New Strong Buy Stock
- Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 03/04/2020
|
What Makes Cardlytics, Inc. (CDLX) a New Strong Buy Stock
- Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 03/04/2020
|
Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year?
- Is (CDLX) Outperforming Other Business Services Stocks This Year?
- 03/04/2020
|
Is Cardlytics (CDLX) Stock Outpacing Its Business Services Peers This Year?
- Is (CDLX) Outperforming Other Business Services Stocks This Year?
- 03/04/2020
|
Story Stocks: Cardlytics is seeing its card denied today as stock falls sharply on earnings/guidance (CDLX)
|
Fly Intel: Pre-market Movers BYND;CPB;VEEV;CNC;DLTR;JWN;HPE;CDLX;URBN;GE
- Fly Intel: Pre-market Movers BYND CPB VEEV CNC DLTR JWN HPE CDLX URBN GE
- 03/04/2020
|
Fly Intel: Pre-market Movers GE;BYND;CPB;VEEV;CNC;DLTR;JWN;HPE;CDLX;URBN
- Fly Intel: Pre-market Movers GE BYND CPB VEEV CNC DLTR JWN HPE CDLX URBN
- 03/04/2020
|
Dow Jones Futures Jump On Super Tuesday Election Results; A Coronavirus Stock Market Correction Survival Guide
- Futures turned higher as Joe Biden won several Super Tuesday states. An Amazon employee tested positive for the coronavirus. Here's a stock market correction survival guide.
- 03/04/2020
|
Cardlytics revamps C-suite, reports FY19 results
- Cardlytics Inc. (NASDAQ: CDLX), which went public in February 2018, works with brands like Starbucks and banks like Chase to deliver ads to specific consumers. Co-founder and Chief Operating Officer Lynne Laube, 50, will take over as CEO from Scott Grimes, who is moving to executive chairman of the board, a newly created role, the company announced Tuesday afternoon. Cardlytics Board Chairman John Balen will become Lead Independent Director.
- 03/04/2020
|
Cardlytics (CDLX) Gets a Buy Rating from SunTrust Robinson
- In a report released yesterday, Youssef Squali from SunTrust Robinson maintained a Buy rating on Cardlytics (CDLX), with a price target of $77.00. The
- 03/04/2020
|
Cardlytics (CDLX) Gets a Buy Rating from SunTrust Robinson
- In a report released yesterday, Youssef Squali from SunTrust Robinson maintained a Buy rating on Cardlytics (CDLX – Research Report),
- 03/04/2020
|
Cardlytics, Inc. (CDLX) CEO Scott Grimes on Q4 2019 Results - Earnings Call Transcript
- Cardlytics, Inc. (NASDAQ:CDLX) Q4 2019 Earnings Conference Call March 03, 2020 5:00 PM ET Company Participants Kirk Somers - Chief Legal & Privacy Officer S
- 03/04/2020
|
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 4.53%
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 4.53%
- 03/04/2020
|
Cardlytics, Inc. (CDLX) Q4 Earnings Top Estimates
- Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 125.00% and -0.04%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- 03/03/2020
|
Cardlytics, Inc. (CDLX) Q4 Earnings Top Estimates
- Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 125.00% and -0.04%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- 03/03/2020
|
Cardlytics -30% amid rough guidance, leadership changes
- Cardlytics (NASDAQ:CDLX) has tumbled 29.9% postmarket after its Q4 earnings topped expectations but guidance for Q1 were short of consensus. The company also set up changes throughout the C-suite: Co
- 03/03/2020
|
Cardlytics stock plunges more than 25% after CEO departure, earnings
- Cardlytics Inc. shares plummeted more than 25% in the extended session Tuesday after the company announced an executive shakeup and earnings. Cardlytics said that co-founder and current Chief Operating Officer Lynne Laube would take over the chief executive job May 15. Current CEO Scott Grimes will become the executive chairman of the board. On March 4, Chief Financial Officer David Evans will move to the chief administrative officer job and Andy Christiansen will take over as CFO. The company reported fourth-quarter net income of $3.4 million, or 12 cents a share, compared with a loss of $11.6 million, or 53 cents a share, in the year-ago period. Revenue rose to $69.3 million from $47.8 million in the year-ago period. Analysts surveyed by FactSet had estimated a loss of 18 cents a share on revenue of $64.6 million. For the first quarter, analysts model a loss of 27 cents a share and sales of $54.1 million. The company said it expected first quarter revenue of $43.5 million to $46.5 million.
- 03/03/2020
|
Cardlytics Announces Fourth Quarter and Fiscal Year 2019 Financial Results
- ATLANTA, March 03, 2020 -- Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and measurable, today announced financial.
- 03/03/2020
|
Cardlytics Announces Fourth Quarter and Fiscal Year 2019 Financial Results
- ATLANTA, March 03, 2020 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant and...
- 03/03/2020
|
One Thing To Remember About The Cardlytics, Inc. (NASDAQ:CDLX) Share Price
- If you own shares in Cardlytics, Inc. (NASDAQ:CDLX) then it's worth thinking about how it contributes to the...
- 03/03/2020
|
Cardlytics (NASDAQ:CDLX) Rating Increased to Hold at ValuEngine
- Cardlytics (NASDAQ:CDLX) was upgraded by research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuEngine reports. CDLX has been the topic of a number of other research reports. BidaskClub cut Cardlytics from a “buy” rating to a “hold” rating in a […]
- 03/03/2020
|
Cardlytics to Help Marketers Solve Major Industry Challenges at South by Southwest, Advertising Week Europe, and Other March Events
- Cardlytics, Inc., (CDLX) is bringing key purchase insights to various industry events throughout the month of March. With a view into more than $2.8 trillion in annual spend, the company uncovers spend trends as they happen, then uses those insights to help marketers identify headroom and reach likely customers in banks’ digital channels. Millennium Alliance Digital Marketing Transformation: Cardlytics will host a roundtable on Tuesday, March 3 at 10:50 a.m. ET at the Millennium Alliance Digital Assembly in Las Vegas.
- 03/02/2020
|
Cardlytics to Help Marketers Solve Major Industry Challenges at South by Southwest, Advertising Week Europe, and Other March Events
- ATLANTA, March 02, 2020 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX) is bringing key purchase insights to various industry events throughout the...
- 03/02/2020
|
BidaskClub Lowers Cardlytics (NASDAQ:CDLX) to Hold
- Cardlytics (NASDAQ:CDLX) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, BidAskClub reports. CDLX has been the subject of a number of other reports. Zacks Investment Research raised shares of Cardlytics from a “hold” rating to a “buy” rating and […]
- 03/02/2020
|
Cardlytics (CDLX) Scheduled to Post Quarterly Earnings on Tuesday
- Cardlytics (NASDAQ:CDLX) will release its earnings data after the market closes on Tuesday, March 3rd. Analysts expect Cardlytics to post earnings of ($0.08) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Cardlytics stock opened at $79.39 on Friday. The stock has […]
- 03/01/2020
|
Cardlytics Inc (NASDAQ:CDLX) CEO Sells $90,000.00 in Stock
- Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 1,000 shares of the company’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $90.00, for a total value of $90,000.00. Following the sale, the chief executive officer now owns 386,403 shares of the company’s stock, valued at $34,776,270. […]
- 02/29/2020
|
American International Group Inc. Boosts Stock Position in Cardlytics Inc (NASDAQ:CDLX)
- American International Group Inc. boosted its holdings in Cardlytics Inc (NASDAQ:CDLX) by 3.2% during the 4th quarter, Holdings Channel reports. The firm owned 8,964 shares of the company’s stock after acquiring an additional 275 shares during the period. American International Group Inc.’s holdings in Cardlytics were worth $563,000 as of its most recent filing with […]
- 02/28/2020
|
Contrasting DouYu International (NASDAQ:DOYU) & Cardlytics (NASDAQ:CDLX)
- DouYu International (NASDAQ:DOYU) and Cardlytics (NASDAQ:CDLX) are both mid-cap consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations. Analyst Recommendations This is a breakdown of current recommendations for DouYu International and Cardlytics, as […]
- 02/27/2020
|
Fmr LLC Purchases 207,626 Shares of Cardlytics Inc (NASDAQ:CDLX)
- Fmr LLC grew its position in shares of Cardlytics Inc (NASDAQ:CDLX) by 5.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,856,756 shares of the company’s stock after acquiring an additional 207,626 shares during the quarter. Fmr LLC […]
- 02/26/2020
|
Cardlytics, Inc. (CDLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/25/2020
|
Cardlytics, Inc. (CDLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/25/2020
|
What You Must Know About Cardlytics, Inc.'s (NASDAQ:CDLX) Beta Value
- If you're interested in Cardlytics, Inc. (NASDAQ:CDLX), then you might want to consider its beta (a measure of share...
- 02/24/2020
|
